| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | SOX9 ASXL1 CALCOCO1 SREBF1 PER1 FOXA2 HNRNPC CREB3L1 SVEP1 PHF21A IKZF5 OVOL2 SALL1 ZC3H4 MITF SNAI2 SMARCA4 RERE PBX2 TOP2A FOXC2 | 2.05e-07 | 739 | 152 | 21 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | SOX9 ATF7 ASXL1 SP100 TCF12 PCLO SREBF1 MED14 PER1 DAXX FOXA2 PIAS2 SALL1 SORBS3 SMARCA4 BSN PBX1 PBX2 SIX2 MED13 | 1.18e-06 | 753 | 152 | 20 | GO:0008134 |
| GeneOntologyMolecularFunction | cAMP response element binding | 1.52e-06 | 12 | 152 | 4 | GO:0035497 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX5 SOX9 ATF7 ZNF536 TCF12 CALCOCO1 SREBF1 PER1 FOXI3 ZNF467 FOXA2 CREB3L1 IKZF5 OVOL2 SALL1 ZBTB25 MITF SNAI2 SMARCA4 PBX1 PBX2 PBX3 MUC1 SIX2 CREB3L2 FOXC2 | 2.41e-06 | 1244 | 152 | 26 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX5 SOX9 ATF7 ZNF536 TCF12 CALCOCO1 SREBF1 PER1 FOXI3 ZNF467 FOXA2 CREB3L1 IKZF5 OVOL2 SALL1 ZBTB25 MITF SNAI2 SMARCA4 PBX1 PBX2 PBX3 MUC1 SIX2 CREB3L2 FOXC2 | 3.56e-06 | 1271 | 152 | 26 | GO:0000987 |
| GeneOntologyMolecularFunction | protein domain specific binding | MICAL1 SP100 TCF12 INSR APBA1 NFASC NLRP1 ARFIP2 FOXA2 DNAJC6 PIAS2 HNRNPC IKZF5 ZNF106 DLC1 UBR5 ARHGAP31 PKD1 IRS2 SRRM2 | 1.11e-05 | 875 | 152 | 20 | GO:0019904 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | SOX9 TCF12 SREBF1 ZNF467 FOXA2 CREB3L1 OVOL2 CSRNP1 MITF PBX1 PBX2 PBX3 SIX2 CREB3L2 FOXC2 | 2.53e-05 | 560 | 152 | 15 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | SOX9 TCF12 SREBF1 ZNF467 FOXA2 CREB3L1 OVOL2 CSRNP1 MITF PBX1 PBX2 PBX3 SIX2 CREB3L2 FOXC2 | 2.86e-05 | 566 | 152 | 15 | GO:0001216 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX5 SOX9 ATF7 ZNF536 TCF12 CALCOCO1 SREBF1 PER1 FOXI3 ZNF467 FOXA2 CREB3L1 IKZF5 OVOL2 SALL1 ZBTB25 MITF SNAI2 SMARCA4 PBX1 PBX2 PBX3 MUC1 SIX2 CREB3L2 FOXC2 | 3.98e-05 | 1459 | 152 | 26 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX5 SOX9 ATF7 SP100 ZNF536 TCF12 SREBF1 FOXI3 ZNF467 FOXA2 CREB3L1 IKZF5 OVOL2 CSRNP1 SALL1 ZBTB25 MITF SNAI2 PBX1 PBX2 PBX3 ZBTB3 SIX2 CREB3L2 FOXC2 | 6.36e-05 | 1412 | 152 | 25 | GO:0000981 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | ASXL1 CNKSR1 UBQLN2 CALCOCO1 MED14 AMBRA1 NLRP1 DAXX SRCAP PIAS2 HNRNPC PHF2 KMT2C TOB1 SETD5 TIRAP MDC1 SMARCA4 IRS2 RERE MUC1 MED13 | 6.84e-05 | 1160 | 152 | 22 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | UBL7 ASXL1 CNKSR1 UBQLN2 CALCOCO1 MED14 AMBRA1 NLRP1 DAXX SRCAP PIAS2 HNRNPC PHF2 KMT2C TOB1 SETD5 TIRAP MDC1 EIF4G1 SMARCA4 IRS2 RERE MUC1 MED13 | 9.14e-05 | 1356 | 152 | 24 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 9.95e-05 | 140 | 152 | 7 | GO:0001221 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | ASXL1 CALCOCO1 MED14 DAXX SRCAP PIAS2 PHF2 KMT2C TOB1 SETD5 SMARCA4 RERE MUC1 MED13 | 1.03e-04 | 562 | 152 | 14 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | ASXL1 CALCOCO1 MED14 DAXX SRCAP PHF2 KMT2C SMARCA4 RERE MED13 | 1.12e-04 | 303 | 152 | 10 | GO:0003713 |
| GeneOntologyMolecularFunction | kinase binding | SOX9 ATF7 MICAL1 SP100 INSR SREBF1 APBA1 PER1 DAXX FOXA2 TOB1 PTPRC TIRAP PKD1 IRS2 MAP2K7 TOP2A BORA | 4.23e-04 | 969 | 152 | 18 | GO:0019900 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SOX9 ASXL1 SP100 TCF12 MED14 PER1 DAXX PIAS2 SALL1 SMARCA4 PBX1 PBX2 MED13 | 5.21e-04 | 582 | 152 | 13 | GO:0140297 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 7.89e-04 | 320 | 152 | 9 | GO:0001227 | |
| GeneOntologyMolecularFunction | ferroxidase activity | 8.46e-04 | 6 | 152 | 2 | GO:0004322 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, oxygen as acceptor | 8.46e-04 | 6 | 152 | 2 | GO:0016724 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 8.99e-04 | 326 | 152 | 9 | GO:0001217 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 1.06e-03 | 59 | 152 | 4 | GO:0001222 | |
| GeneOntologyMolecularFunction | E-box binding | 1.20e-03 | 61 | 152 | 4 | GO:0070888 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.36e-03 | 279 | 152 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.56e-03 | 8 | 152 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 2.00e-03 | 33 | 152 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | protein kinase binding | SOX9 ATF7 MICAL1 INSR SREBF1 APBA1 DAXX TOB1 PTPRC TIRAP PKD1 IRS2 MAP2K7 TOP2A BORA | 2.75e-03 | 873 | 152 | 15 | GO:0019901 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.89e-03 | 127 | 152 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.12e-03 | 187 | 152 | 6 | GO:0016922 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SOX9 ATF7 ASXL1 SP100 TCF12 CALCOCO1 SREBF1 MED14 PER1 DAXX ZNF467 FOXA2 CREB3L1 OVOL2 CSRNP1 KMT2C SALL1 MDC1 PKD1 MITF SMARCA4 LRP5 PBX1 PBX2 PBX3 MUC1 SIX2 TOP2A MED13 CREB3L2 FOXC2 | 2.04e-08 | 1390 | 151 | 31 | GO:0045944 |
| GeneOntologyBiologicalProcess | maintenance of gastrointestinal epithelium | 7.48e-07 | 24 | 151 | 5 | GO:0030277 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 4.67e-06 | 128 | 151 | 8 | GO:0072009 | |
| GeneOntologyBiologicalProcess | epithelial structure maintenance | 6.18e-06 | 36 | 151 | 5 | GO:0010669 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | ASXL1 ZNF536 CALCOCO1 SREBF1 PER1 NLRP1 DAXX PIAS2 UBR5 TIRAP SNAI2 SMARCA4 INAVA | 1.23e-05 | 416 | 151 | 13 | GO:0030522 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.85e-05 | 202 | 151 | 9 | GO:0141193 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular wound healing | 2.10e-05 | 8 | 151 | 3 | GO:0035470 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 2.11e-05 | 258 | 151 | 10 | GO:0001763 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 2.36e-05 | 47 | 151 | 5 | GO:0035850 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 2.61e-05 | 162 | 151 | 8 | GO:0072073 | |
| GeneOntologyBiologicalProcess | cell junction organization | PSD NUMBL PODXL PCLO INSR ADGRB2 NFASC SVEP1 DIP2A DLC1 SETD5 NCAN EIF4G1 SNAI2 LRP5 TMEM108 INAVA BSN SDK1 PLXNB1 | 2.96e-05 | 974 | 151 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | nephron development | 4.35e-05 | 174 | 151 | 8 | GO:0072006 | |
| GeneOntologyBiologicalProcess | synapse organization | PSD NUMBL PODXL PCLO INSR ADGRB2 NFASC DIP2A SETD5 NCAN EIF4G1 LRP5 TMEM108 BSN SDK1 PLXNB1 | 4.39e-05 | 685 | 151 | 16 | GO:0050808 |
| GeneOntologyBiologicalProcess | skeletal system development | SOX5 SOX9 ASXL1 CSRNP1 PTPRC NCAN PKD1 SNAI2 ANKRD11 LRP5 PBX1 SIX2 PLXNB1 CREB3L2 FOXC2 | 4.73e-05 | 615 | 151 | 15 | GO:0001501 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SOX5 SOX9 ASXL1 UBE4B INSR FOXI3 FOXA2 OVOL2 CSRNP1 SALL1 DLC1 PKD1 SNAI2 ANKRD11 SMARCA4 LRP5 PBX1 PBX2 PBX3 SDK1 SIX2 WNK4 FOXC2 | 5.05e-05 | 1269 | 151 | 23 | GO:0009887 |
| GeneOntologyBiologicalProcess | cell differentiation involved in kidney development | 6.06e-05 | 57 | 151 | 5 | GO:0061005 | |
| GeneOntologyBiologicalProcess | bone marrow development | 6.08e-05 | 11 | 151 | 3 | GO:0048539 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 6.23e-05 | 236 | 151 | 9 | GO:0061138 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | SOX9 PODXL FOXA2 OVOL2 SALL1 DLC1 PKD1 LRP5 PBX1 SIX2 WNK4 FOXC2 | 6.52e-05 | 421 | 151 | 12 | GO:0060562 |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 8.04e-05 | 244 | 151 | 9 | GO:0009755 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX5 SOX9 ATF7 SP100 ZNF536 SREBF1 PER1 DAXX CREB3L1 PHF21A IKZF5 OVOL2 SALL1 TOB1 SETD5 ZC3H4 ZBTB25 SORBS3 MITF SNAI2 SMARCA4 RERE MUC1 FOXC2 | 8.08e-05 | 1399 | 151 | 24 | GO:0045892 |
| GeneOntologyBiologicalProcess | synapse assembly | 9.34e-05 | 308 | 151 | 10 | GO:0007416 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX5 SOX9 ATF7 SP100 ZNF536 SREBF1 PER1 DAXX CREB3L1 PHF21A IKZF5 OVOL2 SALL1 TOB1 SETD5 ZC3H4 ZBTB25 SORBS3 MITF SNAI2 SMARCA4 RERE MUC1 FOXC2 | 9.42e-05 | 1413 | 151 | 24 | GO:1902679 |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 1.08e-04 | 198 | 151 | 8 | GO:0048754 | |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 1.59e-04 | 3 | 151 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | kidney morphogenesis | 1.68e-04 | 111 | 151 | 6 | GO:0060993 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | SOX9 PODXL FOXA2 OVOL2 SALL1 DLC1 PKD1 SNAI2 SMARCA4 LRP5 PBX1 SIX2 WNK4 FOXC2 | 1.88e-04 | 619 | 151 | 14 | GO:0002009 |
| GeneOntologyBiologicalProcess | regulation of vascular wound healing | 2.43e-04 | 17 | 151 | 3 | GO:0061043 | |
| GeneOntologyBiologicalProcess | renal vesicle morphogenesis | 2.90e-04 | 18 | 151 | 3 | GO:0072077 | |
| GeneOntologyBiologicalProcess | cell junction assembly | PSD NUMBL PODXL PCLO ADGRB2 NFASC DLC1 SETD5 EIF4G1 SNAI2 BSN SDK1 PLXNB1 | 2.91e-04 | 569 | 151 | 13 | GO:0034329 |
| GeneOntologyBiologicalProcess | chromatin organization | SOX9 ASXL1 PER1 DAXX SRCAP PRDM7 FOXA2 HNRNPC PHF21A PHF2 KMT2C UBR5 SETD5 MDC1 SNAI2 SMARCA4 RERE | 3.10e-04 | 896 | 151 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 3.16e-04 | 4 | 151 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion involved in substrate-bound cell migration | 3.16e-04 | 4 | 151 | 2 | GO:0006933 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal stem cell differentiation | 3.16e-04 | 4 | 151 | 2 | GO:2000741 | |
| GeneOntologyBiologicalProcess | embryo development | SOX5 SOX9 ATF7 ANKS6 INSR AFF3 APBA1 AMBRA1 FOXI3 FOXA2 OVOL2 SALL1 DLC1 PKD1 ANKRD11 SMARCA4 LRP5 PBX1 PBX2 PBX3 SIX2 TOP2A FOXC2 | 3.17e-04 | 1437 | 151 | 23 | GO:0009790 |
| GeneOntologyBiologicalProcess | digestive system process | 3.33e-04 | 126 | 151 | 6 | GO:0022600 | |
| GeneOntologyBiologicalProcess | renal vesicle development | 3.42e-04 | 19 | 151 | 3 | GO:0072087 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | SOX5 SOX9 ATF7 ANKS6 APBA1 AMBRA1 FOXI3 FOXA2 OVOL2 SALL1 DLC1 PKD1 ANKRD11 SMARCA4 PBX1 SIX2 FOXC2 | 3.52e-04 | 906 | 151 | 17 | GO:0043009 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SOX9 ASXL1 MED14 PER1 DAXX SRCAP PRDM7 FOXA2 HNRNPC PHF21A PHF2 KMT2C UBR5 SETD5 MDC1 SNAI2 SMARCA4 RERE | 3.82e-04 | 999 | 151 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | SOX9 CNKSR1 ARHGEF28 INSR SREBF1 SMOC2 CREB3L1 SVEP1 CSRNP1 ZNF106 TMEM108 IRS2 MUC20 FOXC2 VEGFB | 3.95e-04 | 747 | 151 | 15 | GO:0007169 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | SOX9 UBE4B PODXL FOXA2 OVOL2 SALL1 DLC1 PKD1 SNAI2 SMARCA4 LRP5 PBX1 SIX2 WNK4 FOXC2 | 4.12e-04 | 750 | 151 | 15 | GO:0048729 |
| GeneOntologyBiologicalProcess | kidney development | 4.26e-04 | 372 | 151 | 10 | GO:0001822 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 4.34e-04 | 185 | 151 | 7 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 4.34e-04 | 185 | 151 | 7 | GO:0035108 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | INSR AMBRA1 SMOC2 CREB3L1 DBF4 MDC1 EIF4G1 PKD1 SMARCA4 LRP5 PBX1 MUC1 BORA | 4.38e-04 | 594 | 151 | 13 | GO:0007346 |
| GeneOntologyBiologicalProcess | nephron tubule morphogenesis | 4.49e-04 | 87 | 151 | 5 | GO:0072078 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | SOX5 SOX9 ATF7 ANKS6 APBA1 AMBRA1 FOXI3 FOXA2 OVOL2 SALL1 DLC1 PKD1 ANKRD11 SMARCA4 PBX1 SIX2 FOXC2 | 4.69e-04 | 929 | 151 | 17 | GO:0009792 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion mediated by integrin | 4.89e-04 | 50 | 151 | 4 | GO:0033628 | |
| GeneOntologyBiologicalProcess | nephron epithelium morphogenesis | 4.98e-04 | 89 | 151 | 5 | GO:0072088 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 5.01e-04 | 136 | 151 | 6 | GO:0030518 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 5.25e-04 | 5 | 151 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | podocyte differentiation | 5.35e-04 | 22 | 151 | 3 | GO:0072112 | |
| GeneOntologyBiologicalProcess | renal filtration cell differentiation | 5.35e-04 | 22 | 151 | 3 | GO:0061318 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell differentiation | 5.35e-04 | 22 | 151 | 3 | GO:0072311 | |
| GeneOntologyBiologicalProcess | nephron morphogenesis | 5.52e-04 | 91 | 151 | 5 | GO:0072028 | |
| GeneOntologyBiologicalProcess | tube development | SOX9 ASXL1 SP100 PODXL SREBF1 ADGRB2 AMBRA1 SMOC2 FOXA2 CREB3L1 OVOL2 SALL1 DLC1 EIF4G1 PKD1 SMARCA4 LRP5 PBX1 SIX2 WNK4 FOXC2 VEGFB | 5.67e-04 | 1402 | 151 | 22 | GO:0035295 |
| GeneOntologyBiologicalProcess | renal system development | 5.67e-04 | 386 | 151 | 10 | GO:0072001 | |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | 5.94e-04 | 255 | 151 | 8 | GO:0045664 | |
| GeneOntologyBiologicalProcess | renal tubule morphogenesis | 6.09e-04 | 93 | 151 | 5 | GO:0061333 | |
| GeneOntologyBiologicalProcess | metanephric nephron morphogenesis | 6.12e-04 | 23 | 151 | 3 | GO:0072273 | |
| GeneOntologyBiologicalProcess | cartilage condensation | 6.12e-04 | 23 | 151 | 3 | GO:0001502 | |
| GeneOntologyBiologicalProcess | glomerular epithelium development | 6.12e-04 | 23 | 151 | 3 | GO:0072010 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 6.12e-04 | 321 | 151 | 9 | GO:0003007 | |
| GeneOntologyBiologicalProcess | lymph vessel morphogenesis | 6.95e-04 | 24 | 151 | 3 | GO:0036303 | |
| GeneOntologyBiologicalProcess | vascular wound healing | 6.95e-04 | 24 | 151 | 3 | GO:0061042 | |
| GeneOntologyBiologicalProcess | regulation of branching involved in ureteric bud morphogenesis | 6.95e-04 | 24 | 151 | 3 | GO:0090189 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX9 ATF7 SP100 ZNF536 SREBF1 PER1 DAXX CREB3L1 PHF21A IKZF5 OVOL2 SALL1 ZBTB25 SORBS3 MITF SNAI2 SMARCA4 FOXC2 | 7.08e-04 | 1053 | 151 | 18 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of intracellular signal transduction | ASXL1 ZNF536 DUSP7 PER1 PIAS2 CREB3L1 OVOL2 DLC1 PTPRC RASA4 SNAI2 SMARCA4 RASA4B RIPOR1 MUC1 | 7.50e-04 | 795 | 151 | 15 | GO:1902532 |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 7.82e-04 | 148 | 151 | 6 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 7.82e-04 | 148 | 151 | 6 | GO:0035113 | |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 7.83e-04 | 6 | 151 | 2 | GO:0048790 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ARHGEF28 PSD ARHGEF11 DLC1 ARHGAP31 RASA4 RASA4B RIPOR1 PLXNB1 | 7.94e-04 | 333 | 151 | 9 | GO:0051056 |
| GeneOntologyBiologicalProcess | eye development | SOX9 KMT2C RP1L1 MITF SMARCA4 LRP5 PBX1 PBX2 PBX3 SDK1 FOXC2 | 8.35e-04 | 480 | 151 | 11 | GO:0001654 |
| GeneOntologyBiologicalProcess | gland development | SOX9 ATF7 ASXL1 INSR FOXI3 PHF2 PKD1 SNAI2 SMARCA4 LRP5 IRS2 PBX1 | 8.48e-04 | 558 | 151 | 12 | GO:0048732 |
| GeneOntologyBiologicalProcess | visual system development | SOX9 KMT2C RP1L1 MITF SMARCA4 LRP5 PBX1 PBX2 PBX3 SDK1 FOXC2 | 8.79e-04 | 483 | 151 | 11 | GO:0150063 |
| GeneOntologyBiologicalProcess | stem cell development | 8.86e-04 | 101 | 151 | 5 | GO:0048864 | |
| GeneOntologyBiologicalProcess | ossification | SOX9 HNRNPC CREB3L1 TOB1 SNAI2 ANKRD11 LRP3 LRP5 PBX1 SIX2 PLXNB1 FOXC2 | 9.01e-04 | 562 | 151 | 12 | GO:0001503 |
| GeneOntologyBiologicalProcess | mesenchymal cell proliferation | 9.19e-04 | 59 | 151 | 4 | GO:0010463 | |
| GeneOntologyBiologicalProcess | regulation of chondrocyte differentiation | 9.19e-04 | 59 | 151 | 4 | GO:0032330 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | ASXL1 ZNF536 CALCOCO1 INSR SREBF1 PER1 DAXX PIAS2 ZNF106 UBR5 SNAI2 SMARCA4 IRS2 FOXC2 | 9.28e-04 | 727 | 151 | 14 | GO:0032870 |
| GeneOntologyBiologicalProcess | connective tissue development | 9.78e-04 | 343 | 151 | 9 | GO:0061448 | |
| GeneOntologyBiologicalProcess | cell aggregation | 9.89e-04 | 27 | 151 | 3 | GO:0098743 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 9.95e-04 | 155 | 151 | 6 | GO:0043401 | |
| GeneOntologyBiologicalProcess | sensory system development | SOX9 KMT2C RP1L1 MITF SMARCA4 LRP5 PBX1 PBX2 PBX3 SDK1 FOXC2 | 1.00e-03 | 491 | 151 | 11 | GO:0048880 |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 1.02e-03 | 277 | 151 | 8 | GO:0048705 | |
| GeneOntologyBiologicalProcess | stem cell proliferation | 1.03e-03 | 156 | 151 | 6 | GO:0072089 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell maintenance involved in nephron morphogenesis | 1.09e-03 | 7 | 151 | 2 | GO:0072038 | |
| GeneOntologyBiologicalProcess | ureteric bud development | 1.15e-03 | 107 | 151 | 5 | GO:0001657 | |
| GeneOntologyBiologicalProcess | head development | SOX9 NUMBL KIF26A NFASC FOXA2 CSRNP1 SALL1 DLC1 ANKRD11 SMARCA4 TMEM108 IRS2 RERE PBX1 PBX2 PBX3 | 1.17e-03 | 919 | 151 | 16 | GO:0060322 |
| GeneOntologyBiologicalProcess | digestion | 1.17e-03 | 160 | 151 | 6 | GO:0007586 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 1.20e-03 | 108 | 151 | 5 | GO:0035019 | |
| GeneOntologyBiologicalProcess | central nervous system development | SOX5 SOX9 ARHGEF28 NUMBL KIF26A NFASC CERS6 FOXA2 SALL1 DLC1 NCAN SMARCA4 LRP5 TMEM108 IRS2 RERE PBX1 PBX2 PBX3 | 1.21e-03 | 1197 | 151 | 19 | GO:0007417 |
| GeneOntologyBiologicalProcess | endocrine system development | 1.21e-03 | 161 | 151 | 6 | GO:0035270 | |
| GeneOntologyBiologicalProcess | metanephros morphogenesis | 1.22e-03 | 29 | 151 | 3 | GO:0003338 | |
| GeneOntologyBiologicalProcess | mesonephric tubule development | 1.30e-03 | 110 | 151 | 5 | GO:0072164 | |
| GeneOntologyBiologicalProcess | mesonephric epithelium development | 1.30e-03 | 110 | 151 | 5 | GO:0072163 | |
| GeneOntologyBiologicalProcess | nephron tubule development | 1.30e-03 | 110 | 151 | 5 | GO:0072080 | |
| GeneOntologyBiologicalProcess | regulation of morphogenesis of a branching structure | 1.32e-03 | 65 | 151 | 4 | GO:0060688 | |
| GeneOntologyBiologicalProcess | Rho protein signal transduction | 1.33e-03 | 164 | 151 | 6 | GO:0007266 | |
| GeneOntologyBiologicalProcess | limb development | 1.34e-03 | 224 | 151 | 7 | GO:0060173 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.22e-07 | 109 | 155 | 9 | GO:0005796 | |
| GeneOntologyCellularComponent | chromatin | SOX5 SOX9 ATF7 TCF12 CALCOCO1 SREBF1 DAXX SRCAP FOXA2 PIAS2 HNRNPC CREB3L1 CSRNP1 SALL1 UBR5 SETD5 MITF SNAI2 ANKRD11 SMARCA4 PBX1 PBX2 PBX3 MUC1 SIX2 CREB3L2 FOXC2 | 1.17e-05 | 1480 | 155 | 27 | GO:0000785 |
| GeneOntologyCellularComponent | histone deacetylase complex | 4.28e-04 | 85 | 155 | 5 | GO:0000118 | |
| MousePheno | abnormal craniofacial bone morphology | SOX5 SOX9 ASXL1 AFF3 AMBRA1 SMOC2 FOXI3 FOXA2 CSRNP1 DIP2A SETD5 FAM120C PKD1 MITF ANKRD11 SMARCA4 LRP5 PBX1 PBX3 SIX2 CREB3L2 FOXC2 | 5.52e-06 | 827 | 128 | 22 | MP:0002116 |
| MousePheno | abnormal craniofacial development | SOX5 SOX9 FOXI3 FOXA2 OVOL2 DIP2A DLC1 UBR5 PKD1 MITF SNAI2 RERE PBX1 SIX2 FOXC2 | 7.84e-06 | 425 | 128 | 15 | MP:0003935 |
| MousePheno | abnormal cranium morphology | SOX5 SOX9 ASXL1 AFF3 AMBRA1 SMOC2 FOXI3 FOXA2 CSRNP1 DIP2A SETD5 FAM120C PKD1 MITF ANKRD11 SMARCA4 LRP5 PBX1 PBX3 SIX2 FOXC2 | 1.45e-05 | 813 | 128 | 21 | MP:0000438 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | SOX5 SOX9 ASXL1 ANKS6 TCF12 UBE4B PODXL INPP4A INSR AMBRA1 NFASC FOXI3 FOXA2 PHF21A TBC1D24 KMT2C ZNF800 SALL1 CELSR3 SETD5 PKD1 RERE PBX1 PBX3 SIX2 CREB3L2 FOXC2 | 2.57e-05 | 1269 | 128 | 27 | MP:0011111 |
| MousePheno | abnormal mouth morphology | SOX5 SOX9 ASXL1 AFF3 SMOC2 FOXI3 FOXA2 CSRNP1 DIP2A SETD5 MITF SNAI2 RERE PBX1 PBX3 SIX2 CREB3L2 FOXC2 | 3.83e-05 | 670 | 128 | 18 | MP:0000452 |
| MousePheno | increased embryonic tissue cell apoptosis | 8.09e-05 | 153 | 128 | 8 | MP:0013504 | |
| MousePheno | abnormal craniofacial morphology | SOX5 SOX9 ASXL1 AFF3 AMBRA1 SMOC2 FOXI3 FOXA2 OVOL2 CSRNP1 DIP2A DLC1 UBR5 SETD5 FAM120C PKD1 MITF SNAI2 ANKRD11 SMARCA4 LRP5 RERE PBX1 PBX3 SIX2 CREB3L2 FOXC2 | 9.94e-05 | 1372 | 128 | 27 | MP:0000428 |
| MousePheno | craniofacial phenotype | SOX5 SOX9 ASXL1 AFF3 AMBRA1 SMOC2 FOXI3 FOXA2 OVOL2 CSRNP1 DIP2A DLC1 UBR5 SETD5 FAM120C PKD1 MITF SNAI2 ANKRD11 SMARCA4 LRP5 RERE PBX1 PBX3 SIX2 CREB3L2 FOXC2 | 9.94e-05 | 1372 | 128 | 27 | MP:0005382 |
| MousePheno | absent stapes | 1.17e-04 | 11 | 128 | 3 | MP:0004204 | |
| MousePheno | spina bifida | 1.44e-04 | 87 | 128 | 6 | MP:0003054 | |
| MousePheno | abnormal palate morphology | SOX5 SOX9 ASXL1 SMOC2 FOXI3 CSRNP1 SNAI2 RERE PBX1 SIX2 FOXC2 | 1.76e-04 | 321 | 128 | 11 | MP:0003755 |
| MousePheno | digestive/alimentary phenotype | SOX5 SOX9 ASXL1 KIF26A INSR AFF3 WRNIP1 SMOC2 FOXI3 FOXA2 OVOL2 CSRNP1 ZNF800 SALL1 PTPRC CELSR3 SETD5 SIGIRR PKD1 SNAI2 INAVA RERE PBX1 MUC1 MUC4 SIX2 CREB3L2 FOXC2 | 1.78e-04 | 1500 | 128 | 28 | MP:0005381 |
| MousePheno | abnormal facial morphology | SOX5 SOX9 ASXL1 AFF3 AMBRA1 SMOC2 FOXI3 FOXA2 CSRNP1 DIP2A SETD5 MITF SNAI2 ANKRD11 RERE PBX1 PBX3 SIX2 CREB3L2 FOXC2 | 2.21e-04 | 910 | 128 | 20 | MP:0003743 |
| MousePheno | abnormal embryonic tissue cell apoptosis | 2.49e-04 | 180 | 128 | 8 | MP:0013503 | |
| Domain | LRRC37AB_C | 2.14e-06 | 4 | 153 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 2.14e-06 | 4 | 153 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.14e-06 | 4 | 153 | 3 | IPR032754 | |
| Domain | LRRC37 | 2.14e-06 | 4 | 153 | 3 | PF15779 | |
| Domain | PBC | 2.14e-06 | 4 | 153 | 3 | PF03792 | |
| Domain | PBX | 2.14e-06 | 4 | 153 | 3 | IPR005542 | |
| Domain | LRRC37A/B-like | 2.14e-06 | 4 | 153 | 3 | IPR015753 | |
| Domain | VWF_type-D | 7.30e-06 | 16 | 153 | 4 | IPR001846 | |
| Domain | VWFD | 7.30e-06 | 16 | 153 | 4 | PS51233 | |
| Domain | VWD | 7.30e-06 | 16 | 153 | 4 | SM00216 | |
| Domain | VWD | 7.30e-06 | 16 | 153 | 4 | PF00094 | |
| Domain | Znf_piccolo | 6.67e-05 | 2 | 153 | 2 | IPR008899 | |
| Domain | zf-piccolo | 6.67e-05 | 2 | 153 | 2 | PF05715 | |
| Domain | C8 | 1.12e-04 | 12 | 153 | 3 | PF08742 | |
| Domain | TIL | 1.12e-04 | 12 | 153 | 3 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 1.45e-04 | 13 | 153 | 3 | IPR014853 | |
| Domain | C8 | 1.45e-04 | 13 | 153 | 3 | SM00832 | |
| Domain | GPS | 1.66e-04 | 34 | 153 | 4 | SM00303 | |
| Domain | TIL_dom | 1.84e-04 | 14 | 153 | 3 | IPR002919 | |
| Domain | GPS | 1.86e-04 | 35 | 153 | 4 | PF01825 | |
| Domain | MULTICOPPER_OXIDASE2 | 1.99e-04 | 3 | 153 | 2 | PS00080 | |
| Domain | - | 1.99e-04 | 3 | 153 | 2 | 4.10.1130.10 | |
| Domain | GPS | 2.08e-04 | 36 | 153 | 4 | PS50221 | |
| Domain | GPS | 2.32e-04 | 37 | 153 | 4 | IPR000203 | |
| Domain | - | CNKSR1 ARHGEF28 PSD NUMBL APBA1 ARHGEF11 RASA4 MTMR3 OSBPL6 RASA4B IRS2 | 3.86e-04 | 391 | 153 | 11 | 2.30.29.30 |
| Domain | HSA | 3.96e-04 | 4 | 153 | 2 | SM00573 | |
| Domain | Cu-oxidase_2 | 3.96e-04 | 4 | 153 | 2 | IPR011706 | |
| Domain | HSA | 3.96e-04 | 4 | 153 | 2 | PS51204 | |
| Domain | HSA_dom | 3.96e-04 | 4 | 153 | 2 | IPR014012 | |
| Domain | HSA | 3.96e-04 | 4 | 153 | 2 | PF07529 | |
| Domain | Cu-oxidase_2 | 3.96e-04 | 4 | 153 | 2 | PF07731 | |
| Domain | RasGAP_dom | 4.02e-04 | 18 | 153 | 3 | IPR001936 | |
| Domain | VWC_out | 4.74e-04 | 19 | 153 | 3 | SM00215 | |
| Domain | TLDc | 6.56e-04 | 5 | 153 | 2 | SM00584 | |
| Domain | Cu-oxidase_3 | 6.56e-04 | 5 | 153 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 6.56e-04 | 5 | 153 | 2 | PS00079 | |
| Domain | Cu_oxidase_CS | 6.56e-04 | 5 | 153 | 2 | IPR033138 | |
| Domain | Cu-oxidase_3 | 6.56e-04 | 5 | 153 | 2 | PF07732 | |
| Domain | LDLRA_2 | 6.89e-04 | 49 | 153 | 4 | PS50068 | |
| Domain | SEA | 7.40e-04 | 22 | 153 | 3 | PF01390 | |
| Domain | CT | 7.40e-04 | 22 | 153 | 3 | SM00041 | |
| Domain | Rho_GTPase_activation_prot | 7.84e-04 | 88 | 153 | 5 | IPR008936 | |
| Domain | PH_dom-like | CNKSR1 ARHGEF28 PSD NUMBL APBA1 ARHGEF11 RASA4 MTMR3 OSBPL6 RASA4B IRS2 | 7.86e-04 | 426 | 153 | 11 | IPR011993 |
| Domain | SEA | 8.46e-04 | 23 | 153 | 3 | PS50024 | |
| Domain | SEA_dom | 8.46e-04 | 23 | 153 | 3 | IPR000082 | |
| Domain | HMG_box | 9.28e-04 | 53 | 153 | 4 | PF00505 | |
| Domain | TLDc_dom | 9.79e-04 | 6 | 153 | 2 | IPR006571 | |
| Domain | Ubiquilin | 9.79e-04 | 6 | 153 | 2 | IPR015496 | |
| Domain | Cu_oxidase_Cu_BS | 9.79e-04 | 6 | 153 | 2 | IPR002355 | |
| Domain | WxxW_domain | 9.79e-04 | 6 | 153 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 9.79e-04 | 6 | 153 | 2 | PF13330 | |
| Domain | TLD | 9.79e-04 | 6 | 153 | 2 | PF07534 | |
| Domain | HMG | 9.96e-04 | 54 | 153 | 4 | SM00398 | |
| Domain | Cys_knot_C | 1.09e-03 | 25 | 153 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.09e-03 | 25 | 153 | 3 | PS01225 | |
| Domain | Znf_FYVE_PHD | 1.34e-03 | 147 | 153 | 6 | IPR011011 | |
| Domain | AT_hook | 1.36e-03 | 27 | 153 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.36e-03 | 27 | 153 | 3 | IPR017956 | |
| Domain | PDZ | 1.54e-03 | 151 | 153 | 6 | PS50106 | |
| Domain | PDZ | 1.59e-03 | 152 | 153 | 6 | IPR001478 | |
| Domain | HMG_box_dom | 1.99e-03 | 65 | 153 | 4 | IPR009071 | |
| Domain | PH | 2.10e-03 | 278 | 153 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 2.15e-03 | 279 | 153 | 8 | PS50003 | |
| Domain | fn3 | 2.20e-03 | 162 | 153 | 6 | PF00041 | |
| Domain | PH_domain | 2.20e-03 | 280 | 153 | 8 | IPR001849 | |
| Domain | BTK | 2.31e-03 | 9 | 153 | 2 | SM00107 | |
| Domain | Znf_Btk_motif | 2.31e-03 | 9 | 153 | 2 | IPR001562 | |
| Domain | BTK | 2.31e-03 | 9 | 153 | 2 | PF00779 | |
| Domain | ZF_BTK | 2.31e-03 | 9 | 153 | 2 | PS51113 | |
| Domain | C2_dom | 2.34e-03 | 164 | 153 | 6 | IPR000008 | |
| Domain | bZIP_1 | 2.68e-03 | 34 | 153 | 3 | PF00170 | |
| Domain | PTX | 2.87e-03 | 10 | 153 | 2 | SM00159 | |
| Domain | EGF | 3.28e-03 | 235 | 153 | 7 | SM00181 | |
| Domain | TF_DNA-bd | 3.42e-03 | 37 | 153 | 3 | IPR008917 | |
| Domain | GFP-like | 3.49e-03 | 11 | 153 | 2 | IPR023413 | |
| Domain | Pentaxin-related | 3.49e-03 | 11 | 153 | 2 | IPR001759 | |
| Domain | - | 3.49e-03 | 11 | 153 | 2 | 2.40.155.10 | |
| Domain | GAIN_dom_N | 3.49e-03 | 11 | 153 | 2 | IPR032471 | |
| Domain | Pentaxin | 3.49e-03 | 11 | 153 | 2 | PF00354 | |
| Domain | GAIN | 3.49e-03 | 11 | 153 | 2 | PF16489 | |
| Domain | EGF-like_Ca-bd_dom | 3.56e-03 | 124 | 153 | 5 | IPR001881 | |
| Domain | EGF | 3.81e-03 | 126 | 153 | 5 | PF00008 | |
| Domain | - | 3.95e-03 | 449 | 153 | 10 | 3.30.40.10 | |
| Domain | FN3 | 4.23e-03 | 185 | 153 | 6 | SM00060 | |
| Domain | GPCR_2_extracellular_dom | 4.27e-03 | 40 | 153 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 4.27e-03 | 40 | 153 | 3 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 4.27e-03 | 40 | 153 | 3 | PS50227 | |
| Domain | Znf_RING/FYVE/PHD | 4.61e-03 | 459 | 153 | 10 | IPR013083 | |
| Domain | VWF_dom | 4.90e-03 | 42 | 153 | 3 | IPR001007 | |
| Domain | EGF_1 | 5.11e-03 | 255 | 153 | 7 | PS00022 | |
| Domain | TYR_PHOSPHATASE_1 | 5.47e-03 | 86 | 153 | 4 | PS00383 | |
| Domain | RasGAP | 5.69e-03 | 14 | 153 | 2 | SM00323 | |
| Domain | - | 5.69e-03 | 14 | 153 | 2 | 2.60.40.420 | |
| Domain | SEA | 5.69e-03 | 14 | 153 | 2 | SM00200 | |
| Domain | RasGAP_CS | 5.69e-03 | 14 | 153 | 2 | IPR023152 | |
| Domain | TYR_PHOSPHATASE_dom | 5.69e-03 | 87 | 153 | 4 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 5.69e-03 | 87 | 153 | 4 | PS50056 | |
| Domain | EGF-like_CS | 5.79e-03 | 261 | 153 | 7 | IPR013032 | |
| Domain | Ldl_recept_a | 5.95e-03 | 45 | 153 | 3 | PF00057 | |
| Domain | FN3 | 6.01e-03 | 199 | 153 | 6 | PS50853 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.02e-11 | 16 | 114 | 7 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 3.42e-11 | 17 | 114 | 7 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.99e-10 | 21 | 114 | 7 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 4.14e-10 | 23 | 114 | 7 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.09e-09 | 26 | 114 | 7 | M27483 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.55e-09 | 68 | 114 | 9 | M27303 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | MUC16 MUC5B MUC12 NCAN ADAMTS14 MUC1 MUC4 ADAMTSL4 MUC6 MUC20 | 2.33e-07 | 143 | 114 | 10 | M27275 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.33e-07 | 109 | 114 | 9 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.73e-07 | 111 | 114 | 9 | M27416 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 5.09e-07 | 60 | 114 | 7 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 6.40e-07 | 62 | 114 | 7 | M546 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | MUC16 MUC5B MUC12 NCAN ADAMTS14 MUC1 MUC4 ADAMTSL4 MUC6 MUC20 | 3.48e-05 | 250 | 114 | 10 | M27554 |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.39e-04 | 140 | 114 | 7 | M27484 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 3.22e-04 | 17 | 114 | 3 | M47514 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 3.85e-04 | 18 | 114 | 3 | M47516 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | SOX9 TCF12 ARHGEF28 SREBF1 MED14 NFASC ZNF467 FOXA2 ARHGEF11 PIAS2 KMT2C SALL1 PTPRC NCAN EIF4G1 MITF SNAI2 SMARCA4 IRS2 PBX1 SIX2 MED13 PLXNB1 FOXC2 | 4.07e-04 | 1432 | 114 | 24 | M509 |
| Pathway | REACTOME_SUMOYLATION | 4.41e-04 | 169 | 114 | 7 | MM14919 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 5.31e-04 | 20 | 114 | 3 | M47517 | |
| Pathway | REACTOME_FORMATION_OF_THE_URETERIC_BUD | 6.16e-04 | 21 | 114 | 3 | M48244 | |
| Pathway | WP_FOXA2_PATHWAY | 6.16e-04 | 21 | 114 | 3 | M42579 | |
| Pathway | REACTOME_IRS_ACTIVATION | 6.38e-04 | 5 | 114 | 2 | M27707 | |
| Pathway | REACTOME_SUMOYLATION | 8.57e-04 | 189 | 114 | 7 | M27214 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 5.76e-15 | 18 | 156 | 8 | 18834073 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ANKS6 UBE4B KIF26A SREBF1 ADGRB2 MED14 PER1 AMBRA1 TBC1D25 SRCAP ANKHD1 ARHGEF11 TBC1D24 KMT2C DIP2A CELSR3 SETD5 EIF4G1 PKD1 SORBS3 MTMR3 ANKRD11 LRP3 LRP5 RIPOR1 IRS2 MED13 | 7.25e-13 | 1105 | 156 | 27 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SFSWAP UBE4B MYO18A WRNIP1 MED14 DAXX HNRNPC ZNF106 PTPRC ZC3H4 DBF4 MDC1 EIF4G1 SORBS3 SMARCA4 RIPOR1 IRS2 RERE SRRM2 TOP2A MED13 | 4.91e-11 | 774 | 156 | 21 | 15302935 |
| Pubmed | 3.89e-10 | 4 | 156 | 4 | 21596555 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX5 SOX9 ATF7 SP100 TCF12 SREBF1 CERS6 PRDM7 FOXI3 FOXA2 CREB3L1 SALL1 MITF SNAI2 RERE PBX1 PBX2 PBX3 SIX2 CREB3L2 FOXC2 | 8.83e-10 | 908 | 156 | 21 | 19274049 |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 1.94e-09 | 5 | 156 | 4 | 11062147 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 1.94e-09 | 5 | 156 | 4 | 16475027 | |
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 19110483 | ||
| Pubmed | SP100 ZNF536 TCF12 PSD SFSWAP WRNIP1 PER1 AMBRA1 SRCAP ANKHD1 PHF21A PHF2 UBR5 SETD5 FAM120C ZC3H4 SMARCA4 IRS2 RERE SRRM2 MAP2K7 TOP2A | 6.32e-09 | 1116 | 156 | 22 | 31753913 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SOX5 ZNF536 PIAS2 PHF21A KMT2C SALL1 MDC1 MITF SMARCA4 RERE PBX1 PBX2 TOP2A | 7.69e-09 | 351 | 156 | 13 | 38297188 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJB12 ATF7 NUMBL UBE4B INPP4A CALCOCO1 INSR AFF3 NFASC CERS6 SMOC2 HNRNPC PHF2 KMT2C SETD5 FAM120C SIGIRR ANKRD11 LRP5 RIPOR1 RERE PBX1 PBX2 PBX3 CREB3L2 | 1.30e-08 | 1489 | 156 | 25 | 28611215 |
| Pubmed | KIF26A AMBRA1 NFASC ANKRD50 ANKHD1 PHF21A TBC1D24 KMT2C CELSR3 ARHGAP31 ZC3H4 MDC1 BSN MED13 PLXNB1 | 1.87e-08 | 529 | 156 | 15 | 14621295 | |
| Pubmed | 2.69e-08 | 8 | 156 | 4 | 31625560 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ATF7 ASXL1 ZNF536 TCF12 WRNIP1 PER1 ANKHD1 FOXA2 PHF21A SALL1 UBR5 EIF4G1 SMARCA4 PBX1 PBX2 PBX3 TOP2A FOXC2 | 6.59e-08 | 857 | 156 | 18 | 25609649 |
| Pubmed | SOX5 CNKSR1 UBQLN2 INPP4A PIAS2 SVEP1 ZNF106 PTPRC SUSD1 UBR5 EIF4G1 PKD1 LRP5 ZBTB3 SDK1 | 7.95e-08 | 591 | 156 | 15 | 15231748 | |
| Pubmed | A unique stylopod patterning mechanism by Shox2-controlled osteogenesis. | 8.01e-08 | 10 | 156 | 4 | 27287812 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 23053434 | ||
| Pubmed | Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression. | 8.85e-08 | 3 | 156 | 3 | 23305535 | |
| Pubmed | The TALE homeodomain protein Pbx2 is not essential for development and long-term survival. | 8.85e-08 | 3 | 156 | 3 | 15169896 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 24714692 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 30236127 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 26770020 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 10679934 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 27483328 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 24939955 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 23446997 | ||
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 8.85e-08 | 3 | 156 | 3 | 17592322 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 22402132 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 11468159 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 35879412 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | SOX9 SP100 TCF12 CALCOCO1 SREBF1 PER1 DAXX ZNF467 PIAS2 CREB3L1 PHF2 ZBTB25 MITF RERE PBX1 PBX2 PBX3 ZBTB3 | 9.29e-08 | 877 | 156 | 18 | 20211142 |
| Pubmed | SOX5 SOX9 ASXL1 ZNF536 TCF12 MYO18A SRCAP ANKHD1 MCRIP1 PIAS2 PHF21A IKZF5 PHF2 KMT2C SALL1 MDC1 EIF4G1 MITF SMARCA4 RERE PBX1 PBX2 SRRM2 | 1.13e-07 | 1429 | 156 | 23 | 35140242 | |
| Pubmed | SOX5 SOX9 ZNF536 TCF12 SREBF1 ZNF467 PHF21A KMT2C SNAI2 SMARCA4 PBX1 PBX2 PBX3 ZBTB3 SIX2 FOXC2 | 1.42e-07 | 709 | 156 | 16 | 22988430 | |
| Pubmed | 1.87e-07 | 12 | 156 | 4 | 20627960 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 25638393 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 3.53e-07 | 4 | 156 | 3 | 22269464 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 22419166 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 23807779 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 21647207 | ||
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 3.53e-07 | 4 | 156 | 3 | 39024979 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 33154304 | ||
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 3.53e-07 | 4 | 156 | 3 | 24901817 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 36367122 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 17471237 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 3.53e-07 | 4 | 156 | 3 | 29869461 | |
| Pubmed | Pbx/Meis deficiencies demonstrate multigenetic origins of congenital heart disease. | 3.53e-07 | 4 | 156 | 3 | 18723445 | |
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 3.53e-07 | 4 | 156 | 3 | 20929551 | |
| Pubmed | PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. | 3.53e-07 | 4 | 156 | 3 | 1682799 | |
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 3.53e-07 | 4 | 156 | 3 | 27298226 | |
| Pubmed | Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. | 3.53e-07 | 4 | 156 | 3 | 18198997 | |
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 3.53e-07 | 4 | 156 | 3 | 17401217 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 12676567 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 25298197 | ||
| Pubmed | Control of pelvic girdle development by genes of the Pbx family and Emx2. | 3.76e-07 | 14 | 156 | 4 | 21455939 | |
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 8.79e-07 | 5 | 156 | 3 | 16188033 | |
| Pubmed | Transcription factor PBX4 regulates limb development and haematopoiesis in mice. | 8.79e-07 | 5 | 156 | 3 | 38230761 | |
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 17058067 | ||
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 10842069 | ||
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 24840470 | ||
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 18035521 | ||
| Pubmed | Pbx4, a new Pbx family member on mouse chromosome 8, is expressed during spermatogenesis. | 8.79e-07 | 5 | 156 | 3 | 11335119 | |
| Pubmed | HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. | 8.79e-07 | 5 | 156 | 3 | 10082572 | |
| Pubmed | 1.17e-06 | 119 | 156 | 7 | 23508102 | ||
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 1.43e-06 | 43 | 156 | 5 | 34672947 | |
| Pubmed | The PBX-regulating protein PREP1 is present in different PBX-complexed forms in mouse. | 1.75e-06 | 6 | 156 | 3 | 10381567 | |
| Pubmed | Characterization of TALE genes expression during the first lineage segregation in mammalian embryos. | 1.75e-06 | 6 | 156 | 3 | 22987645 | |
| Pubmed | TRIM46 MICAL1 OXR1 NUMBL INPP4A PCLO CALCOCO1 MYO18A WRNIP1 NFASC ARHGEF11 DNAJC6 HNRNPC TBC1D24 DIP2A FAM120C NCAN EIF4G1 OSBPL6 SMARCA4 BSN | 1.86e-06 | 1431 | 156 | 21 | 37142655 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DNAJB12 SP100 TMEM201 UBE4B PODXL SREBF1 EI24 NFASC ZNF467 FOXA2 PIAS2 HNRNPC TBC1D24 ZNF106 ZNF800 EIF4G1 RERE SRRM2 TOP2A | 2.09e-06 | 1203 | 156 | 19 | 29180619 |
| Pubmed | 2.18e-06 | 251 | 156 | 9 | 29031500 | ||
| Pubmed | 2.20e-06 | 21 | 156 | 4 | 29659575 | ||
| Pubmed | SP100 KIF26A MYO18A DAXX MUC12 ARHGEF11 PIAS2 KMT2C ZNF106 KIAA1549L ARHGAP31 MUC1 | 2.21e-06 | 486 | 156 | 12 | 20936779 | |
| Pubmed | Conserved and Divergent Molecular and Anatomic Features of Human and Mouse Nephron Patterning. | 2.68e-06 | 22 | 156 | 4 | 29449451 | |
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 12488434 | ||
| Pubmed | SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes. | 3.06e-06 | 7 | 156 | 3 | 21779164 | |
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 12397630 | ||
| Pubmed | 3.23e-06 | 23 | 156 | 4 | 18691704 | ||
| Pubmed | E-cadherin is required for intestinal morphogenesis in the mouse. | 3.86e-06 | 24 | 156 | 4 | 22766025 | |
| Pubmed | SOX5 ATF7 TCF12 SREBF1 SRCAP PIAS2 PHF21A IKZF5 OVOL2 PHF2 SALL1 DBF4 PBX2 PBX3 CREB3L2 | 3.96e-06 | 808 | 156 | 15 | 20412781 | |
| Pubmed | The transcription factor Sox5 modulates Sox10 function during melanocyte development. | 4.88e-06 | 8 | 156 | 3 | 18703590 | |
| Pubmed | Hoxa2 downregulates Six2 in the neural crest-derived mesenchyme. | 4.88e-06 | 8 | 156 | 3 | 15634706 | |
| Pubmed | Enhancer redundancy provides phenotypic robustness in mammalian development. | 4.88e-06 | 8 | 156 | 3 | 29420474 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SP100 TCF12 NUMBL DAXX PIAS2 PHF21A ZNF106 SALL1 EIF4G1 MITF TOP2A | 5.75e-06 | 444 | 156 | 11 | 34795231 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ATF7 TMEM201 SFSWAP SREBF1 EI24 SRCAP HNRNPC PHF21A PHF2 KMT2C ZNF106 MDC1 MITF ANKRD11 SMARCA4 SRRM2 SIX2 TOP2A CREB3L2 | 5.96e-06 | 1294 | 156 | 19 | 30804502 |
| Pubmed | Meis homeoproteins directly regulate Pax6 during vertebrate lens morphogenesis. | 7.29e-06 | 9 | 156 | 3 | 12183364 | |
| Pubmed | Bone morphology is regulated modularly by global and regional genetic programs. | 7.29e-06 | 9 | 156 | 3 | 31221640 | |
| Pubmed | A highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscle. | 7.29e-06 | 9 | 156 | 3 | 18676817 | |
| Pubmed | Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system. | 7.62e-06 | 60 | 156 | 5 | 29055695 | |
| Pubmed | 8.25e-06 | 105 | 156 | 6 | 9628581 | ||
| Pubmed | 1.04e-05 | 10 | 156 | 3 | 23064749 | ||
| Pubmed | 1.04e-05 | 10 | 156 | 3 | 34716243 | ||
| Pubmed | 1.15e-05 | 234 | 156 | 8 | 36243803 | ||
| Pubmed | Mechanosignalling via integrins directs fate decisions of pancreatic progenitors. | 1.27e-05 | 32 | 156 | 4 | 30487608 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | ATF7 TMEM201 SFSWAP WRNIP1 PIAS2 HNRNPC IKZF5 SALL1 SMARCA4 PBX1 PBX2 PBX3 | 1.39e-05 | 583 | 156 | 12 | 29844126 |
| Pubmed | 1.42e-05 | 11 | 156 | 3 | 29437830 | ||
| Pubmed | ASXL1 ZNF536 UBE4B DNAJC6 UBR5 SETD5 MTMR3 RIPOR1 RERE SRRM2 | 1.66e-05 | 407 | 156 | 10 | 12693553 | |
| Pubmed | 1.89e-05 | 12 | 156 | 3 | 21945074 | ||
| Pubmed | A TALE/HOX code unlocks WNT signalling response towards paraxial mesoderm. | 1.89e-05 | 12 | 156 | 3 | 34446717 | |
| Pubmed | 1.89e-05 | 12 | 156 | 3 | 20573694 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | ANKS6 TCF12 NUMBL DUSP7 WRNIP1 PER1 DAXX ANKRD50 HNRNPC UBR5 DBF4 MITF RIPOR1 IRS2 MAP2K7 BORA | 1.89e-05 | 1038 | 156 | 16 | 26673895 |
| Interaction | TOP3B interactions | ANKS6 UBE4B KIF26A SREBF1 APBA1 ADGRB2 MED14 PER1 AMBRA1 TBC1D25 SRCAP ANKHD1 ARHGEF11 TBC1D24 KMT2C DIP2A CELSR3 SETD5 FAM120C MDC1 EIF4G1 PKD1 SORBS3 MTMR3 ANKRD11 LRP3 LRP5 RIPOR1 IRS2 ADAMTSL4 MED13 | 2.26e-07 | 1470 | 155 | 31 | int:TOP3B |
| Interaction | GSC interactions | 4.85e-06 | 87 | 155 | 7 | int:GSC | |
| Interaction | PIN1 interactions | CNKSR1 TCF12 UBQLN2 APBA1 WRNIP1 DAXX TFG HNRNPC SNCAIP PBX1 SRRM2 ADAMTSL4 TOP2A | 8.62e-06 | 383 | 155 | 13 | int:PIN1 |
| Interaction | EYA3 interactions | 2.09e-05 | 73 | 155 | 6 | int:EYA3 | |
| Interaction | C5orf24 interactions | 3.31e-05 | 48 | 155 | 5 | int:C5orf24 | |
| Cytoband | 17q21-q22 | 1.71e-04 | 6 | 156 | 2 | 17q21-q22 | |
| GeneFamily | CD molecules|Mucins | 3.44e-13 | 21 | 113 | 8 | 648 | |
| GeneFamily | PDZ domain containing | 3.86e-04 | 152 | 113 | 6 | 1220 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 5.57e-04 | 26 | 113 | 3 | 526 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.69e-03 | 10 | 113 | 2 | 830 | |
| GeneFamily | PHD finger proteins | 2.45e-03 | 90 | 113 | 4 | 88 | |
| GeneFamily | Low density lipoprotein receptors | 2.89e-03 | 13 | 113 | 2 | 634 | |
| GeneFamily | Fibronectin type III domain containing | 3.32e-03 | 160 | 113 | 5 | 555 | |
| GeneFamily | Basic leucine zipper proteins | 3.55e-03 | 49 | 113 | 3 | 506 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.85e-03 | 15 | 113 | 2 | 26 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 3.85e-03 | 15 | 113 | 2 | 1296 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF536 PRDM7 ZNF467 IKZF5 OVOL2 ZNF106 ZNF800 SALL1 ZBTB25 SNAI2 ZBTB3 | 5.30e-03 | 718 | 113 | 11 | 28 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.44e-03 | 57 | 113 | 3 | 1179 | |
| GeneFamily | SRY-boxes | 6.18e-03 | 19 | 113 | 2 | 757 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_DN | 1.73e-07 | 185 | 156 | 10 | M1137 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN | 1.82e-07 | 186 | 156 | 10 | M1140 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_DN | 3.73e-07 | 201 | 156 | 10 | MM500 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN | 3.73e-07 | 201 | 156 | 10 | MM502 | |
| Coexpression | KIM_WT1_TARGETS_12HR_UP | SOX9 OXR1 PODXL CALCOCO1 MYO18A CREB3L1 SNAI2 RIPOR1 CREB3L2 | 7.10e-07 | 166 | 156 | 9 | M15535 |
| Coexpression | NABA_ECM_AFFILIATED | 8.66e-07 | 170 | 156 | 9 | M5880 | |
| Coexpression | DARWICHE_SKIN_TUMOR_PROMOTER_DN | 2.59e-06 | 194 | 156 | 9 | M1132 | |
| Coexpression | GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP | 3.32e-06 | 200 | 156 | 9 | M6606 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SOX9 ASXL1 SP100 TCF12 PODXL CERS6 PHF21A DLC1 UBR5 ZC3H4 DBF4 MITF MTMR3 AKAP10 PBX3 TOP2A MED13 CREB3L2 | 3.69e-06 | 856 | 156 | 18 | M4500 |
| Coexpression | NABA_ECM_AFFILIATED | 4.97e-06 | 158 | 156 | 8 | MM17063 | |
| Coexpression | GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 8.16e-06 | 169 | 156 | 8 | M9087 | |
| Coexpression | DARWICHE_SKIN_TUMOR_PROMOTER_DN | 8.63e-06 | 225 | 156 | 9 | MM496 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_DN | 9.28e-06 | 172 | 156 | 8 | M1134 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TRIM46 UBQLN2 PSD INPP4A PCLO AFF3 APBA1 NFASC CERS6 DNAJC6 PIAS2 TBC1D24 KIAA1549L CELSR3 RASA4 NCAN OSBPL6 BSN PBX3 MUC2 | 9.77e-06 | 1106 | 156 | 20 | M39071 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | PSD NUMBL PCLO INSR NLRP1 CERS6 ARHGEF11 TBC1D24 RASA4 PKD1 RASA4B SDK1 | 1.07e-05 | 429 | 156 | 12 | M45694 |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_DN | 1.64e-05 | 186 | 156 | 8 | MM498 | |
| Coexpression | LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES | 2.41e-05 | 10 | 156 | 3 | M39249 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 2.66e-05 | 199 | 156 | 8 | M6987 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 2.76e-05 | 200 | 156 | 8 | M9260 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | TMEM201 SFSWAP APBA1 SRCAP ARHGEF11 PHF21A SETD5 SMARCA4 PBX2 SRRM2 | 3.70e-05 | 338 | 156 | 10 | M17094 |
| Coexpression | JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP | 4.45e-05 | 107 | 156 | 6 | M13424 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 5.60e-05 | 221 | 156 | 8 | M39222 | |
| Coexpression | GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP | 6.12e-05 | 165 | 156 | 7 | M337 | |
| Coexpression | KIM_WT1_TARGETS_8HR_UP | 6.60e-05 | 167 | 156 | 7 | M8857 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | SOX9 ZNF536 PODXL ADGRB2 SMOC2 CREB3L1 SVEP1 OVOL2 STAC2 SNCAIP SALL1 DLC1 SIGIRR LRP5 TMEM108 INAVA TOP2A WNK4 | 7.49e-05 | 1074 | 156 | 18 | M1941 |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP | AFF3 ADGRB2 CERS6 ARFIP2 ZNF467 CREB3L1 TOB1 LRP3 PBX1 SRRM2 | 1.09e-04 | 385 | 156 | 10 | M2840 |
| Coexpression | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN | 1.32e-04 | 17 | 156 | 3 | M1776 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | UBQLN2 PCLO SREBF1 NFASC FOXA2 DNAJC6 HNRNPC TBC1D24 KMT2C ZNF106 RASA4 IRS2 RERE SIX2 CREB3L2 VEGFB | 1.73e-04 | 946 | 156 | 16 | M39169 |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP | 1.79e-04 | 196 | 156 | 7 | M6227 | |
| Coexpression | GSE28408_LY6G_POS_VS_NEG_DC_UP | 1.84e-04 | 197 | 156 | 7 | M9547 | |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 1.84e-04 | 197 | 156 | 7 | M8983 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | INPP4A MYO18A CERS6 IKZF5 KMT2C SNCAIP TOB1 PTPRC GVINP1 ARHGAP31 RNFT1 RIPOR1 PBX2 MED13 FOXC2 | 1.86e-04 | 854 | 156 | 15 | M1533 |
| Coexpression | GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 1.90e-04 | 198 | 156 | 7 | M5335 | |
| Coexpression | GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP | 1.90e-04 | 198 | 156 | 7 | M7875 | |
| Coexpression | GSE13493_DP_VS_CD8POS_THYMOCYTE_UP | 1.96e-04 | 199 | 156 | 7 | M3314 | |
| Coexpression | GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_UP | 1.96e-04 | 199 | 156 | 7 | M8562 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 1.96e-04 | 199 | 156 | 7 | M7254 | |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN | 2.02e-04 | 200 | 156 | 7 | M9453 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 2.02e-04 | 200 | 156 | 7 | M8050 | |
| Coexpression | GSE27786_LIN_NEG_VS_MONO_MAC_UP | 2.02e-04 | 200 | 156 | 7 | M4796 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN | 2.02e-04 | 200 | 156 | 7 | M5167 | |
| Coexpression | GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN | 2.02e-04 | 200 | 156 | 7 | M7801 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | TRIM46 PSD LRRC37A3 APBA1 NFASC DNAJC6 RASA4 OSBPL6 BSN PBX1 PBX3 | 2.64e-04 | 513 | 156 | 11 | M39069 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | SOX9 ANKS6 TCF12 NUMBL DUSP7 CALCOCO1 AFF3 ADGRB2 PER1 ARHGEF11 DNAJC6 SVEP1 PHF21A STAC2 SNCAIP KIAA1549L GVINP1 SETD5 ARHGAP31 PKD1 SORBS3 SNAI2 RIPOR1 IRS2 PBX3 SDK1 SIX2 WNK4 CREB3L2 | 9.24e-09 | 1208 | 153 | 29 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | TRIM46 SOX5 SOX9 MICAL1 ZNF536 ANKS6 NUMBL AFF3 ADGRB2 CERS6 SMOC2 FOXA2 CREB3L1 SVEP1 STAC2 SNCAIP RASA4 SORBS3 SNAI2 OSBPL6 PRR14L SIX2 WNK4 CREB3L2 | 2.45e-06 | 1148 | 153 | 24 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | TRIM46 SOX5 SOX9 ATF7 ANKS6 NUMBL AFF3 ADGRB2 PER1 ANKRD50 SMOC2 SVEP1 STAC2 SNCAIP PKD1 SORBS3 SNAI2 OSBPL6 LRP5 PRR14L SIX2 WNK4 CREB3L2 | 2.40e-05 | 1228 | 153 | 23 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | SOX9 TCF12 SFSWAP OXR1 KIF26A INPP4A CALCOCO1 APBA1 PER1 CP ZNF467 PIAS2 PHF21A SALL1 UBR5 RASA4 PKD1 RASA4B PBX1 PBX2 SRRM2 SDK1 SIX2 | 2.97e-05 | 1245 | 153 | 23 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.09e-05 | 227 | 153 | 9 | gudmap_kidney_adult_RenCorpuscGlomer_k2_1000 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | SOX9 SREBF1 MUC5B CERS6 MUC12 FOXA2 CREB3L1 MUC1 MUC4 WNK4 PLXNB1 | 1.15e-10 | 197 | 156 | 11 | e14a0e8a893c72356afc5508e3531ae0b23bfe16 |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | SOX9 SREBF1 MUC5B CERS6 MUC12 FOXA2 CREB3L1 MUC1 MUC4 WNK4 PLXNB1 | 1.15e-10 | 197 | 156 | 11 | 19cf283537c853fa902852e7b8ac1139729a931a |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | SOX9 SREBF1 MUC5B CERS6 MUC12 FOXA2 CREB3L1 MUC1 MUC4 WNK4 PLXNB1 | 1.21e-10 | 198 | 156 | 11 | 9c0535099750698daac5d6b4d39fb19fecf4ffde |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.76e-10 | 178 | 156 | 10 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | SOX9 SMOC2 SVEP1 SNCAIP KIAA1549L SNAI2 TMEM108 BSN WNK4 FOXC2 | 1.70e-09 | 193 | 156 | 10 | cf2461af78f65616ce40d552ee9452295e3895ed |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | SOX9 SMOC2 SVEP1 SNCAIP KIAA1549L SNAI2 TMEM108 BSN WNK4 FOXC2 | 1.70e-09 | 193 | 156 | 10 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | SOX9 SMOC2 SVEP1 SNCAIP KIAA1549L SNAI2 TMEM108 BSN WNK4 FOXC2 | 1.70e-09 | 193 | 156 | 10 | e4ea7ce011a80b81b841c907719aa532bed39d2e |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-09 | 198 | 156 | 10 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-08 | 175 | 156 | 9 | 019ea30ac55748463d7917abf3d3f0e804189bfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.68e-08 | 199 | 156 | 9 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.68e-08 | 199 | 156 | 9 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.68e-08 | 199 | 156 | 9 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| ToppCell | (04)_Interm._basal>secr.|World / shred by cell type by condition | 3.68e-08 | 199 | 156 | 9 | ed399244433f781fc291a9bff16825b8a3ca294f | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.68e-08 | 199 | 156 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.68e-08 | 199 | 156 | 9 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.68e-08 | 199 | 156 | 9 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.68e-08 | 199 | 156 | 9 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.49e-08 | 159 | 156 | 8 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 2.07e-07 | 176 | 156 | 8 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-07 | 184 | 156 | 8 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-07 | 189 | 156 | 8 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 3.71e-07 | 190 | 156 | 8 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.18e-07 | 193 | 156 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.52e-07 | 195 | 156 | 8 | 2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464 | |
| ToppCell | Goblet_1|World / shred by cell class for nasal brushing | 4.52e-07 | 195 | 156 | 8 | d9e4889a2e7b7c97c07c15b043b77837739462e4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.52e-07 | 195 | 156 | 8 | 576142b4e75457c0973051bccc4163bd624496af | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.52e-07 | 195 | 156 | 8 | 8f151066ad3ebd9661ea0b733f03c2ce1518f9ad | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 4.70e-07 | 196 | 156 | 8 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 4.70e-07 | 196 | 156 | 8 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | 21-Trachea-Epithelial-Club-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 5.07e-07 | 198 | 156 | 8 | e735d82e5151c98b5724c543f8ad633c8ed824d2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.07e-07 | 198 | 156 | 8 | 28ada093cec552262731194a04a4b9ff93186c3b | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.07e-07 | 198 | 156 | 8 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.07e-07 | 198 | 156 | 8 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.07e-07 | 198 | 156 | 8 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.07e-07 | 198 | 156 | 8 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.27e-07 | 199 | 156 | 8 | a706ad5cd5e0dc8d7e925a05e45b07d35963f294 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.47e-07 | 200 | 156 | 8 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 5.47e-07 | 200 | 156 | 8 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.47e-07 | 200 | 156 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 1.02e-06 | 150 | 156 | 7 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-06 | 161 | 156 | 7 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 169 | 156 | 7 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-06 | 169 | 156 | 7 | 40b557549fe08c5dc9dba359af35993d68d1640a | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.27e-06 | 169 | 156 | 7 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-06 | 171 | 156 | 7 | eddc5e05003382603ee49f74b9e2242a43021096 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.65e-06 | 173 | 156 | 7 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.75e-06 | 174 | 156 | 7 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-06 | 175 | 156 | 7 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-06 | 175 | 156 | 7 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.97e-06 | 176 | 156 | 7 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-06 | 177 | 156 | 7 | e5070934c674a46e070b0d52b9a374516bf6aea1 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-06 | 177 | 156 | 7 | b37d821f4f3204daf7c568ac17a0af0ba97273d6 | |
| ToppCell | Club_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.20e-06 | 178 | 156 | 7 | be64d4be23fb96a4cdd7980c58880fdfe817747f | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 3.32e-06 | 179 | 156 | 7 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-06 | 179 | 156 | 7 | 6405010e8136a4d9bab356f628e36e3194911112 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 3.84e-06 | 183 | 156 | 7 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.84e-06 | 183 | 156 | 7 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-06 | 186 | 156 | 7 | e52cf44989c57c433bf82e9fa13b4643e88f3577 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-06 | 186 | 156 | 7 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-06 | 186 | 156 | 7 | 4c0b59d845b79323e7a3287e7c4d249f5f322556 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.42e-06 | 187 | 156 | 7 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.42e-06 | 187 | 156 | 7 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.42e-06 | 187 | 156 | 7 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-06 | 187 | 156 | 7 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.58e-06 | 188 | 156 | 7 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 4.74e-06 | 189 | 156 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.91e-06 | 190 | 156 | 7 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.91e-06 | 190 | 156 | 7 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.91e-06 | 190 | 156 | 7 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.91e-06 | 190 | 156 | 7 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.91e-06 | 190 | 156 | 7 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.08e-06 | 191 | 156 | 7 | 30e7cc5f7eadf90ab0900a73fdfe48f9a1adcbfb | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.08e-06 | 191 | 156 | 7 | 41d2f5278f6d5f52a5bdf4f3df70969481c00162 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.08e-06 | 191 | 156 | 7 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.08e-06 | 191 | 156 | 7 | 14851529025cfc2b665f71ebad04150ec543da7a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-06 | 191 | 156 | 7 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.08e-06 | 191 | 156 | 7 | e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-06 | 192 | 156 | 7 | bf187a57a559ab732bb815892af45ca922966ac6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.26e-06 | 192 | 156 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 5.26e-06 | 192 | 156 | 7 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.44e-06 | 193 | 156 | 7 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.44e-06 | 193 | 156 | 7 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.63e-06 | 194 | 156 | 7 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.63e-06 | 194 | 156 | 7 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 194 | 156 | 7 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 194 | 156 | 7 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 5.82e-06 | 195 | 156 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.82e-06 | 195 | 156 | 7 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | 3'-Airway_Nasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.82e-06 | 195 | 156 | 7 | 7ffbdbe95b248699bf6300322d084d21a4a4b1b8 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-06 | 196 | 156 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.02e-06 | 196 | 156 | 7 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.02e-06 | 196 | 156 | 7 | 847b3377f463bfded046eec63cc1b547f3dc33c1 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Mucous-Mucous|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.02e-06 | 196 | 156 | 7 | 357a5440aeebf69688bfe9fbc8585950ad00906b | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Mucous|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.02e-06 | 196 | 156 | 7 | 98e3f9c886063def16c74ab75fc81511a7872f1c | |
| ToppCell | 3'-Airway_Nasal-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.02e-06 | 196 | 156 | 7 | eadc3e60104214cb5f6cfb098a5c5ea0f83d15bd | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.22e-06 | 197 | 156 | 7 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.22e-06 | 197 | 156 | 7 | d624f3a105b19f19a0dd253ce8de3ed13adc1f01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-06 | 197 | 156 | 7 | adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131 | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.22e-06 | 197 | 156 | 7 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.43e-06 | 198 | 156 | 7 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 6.34e-06 | 191 | 154 | 9 | 7417_UP | |
| Drug | geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A | SP100 ARHGEF28 MED14 PIAS2 SORBS3 SMARCA4 RIPOR1 PRR14L MUC1 | 6.89e-06 | 193 | 154 | 9 | 1228_DN |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 7.49e-06 | 195 | 154 | 9 | 5330_UP | |
| Drug | Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 7.81e-06 | 196 | 154 | 9 | 7345_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 8.14e-06 | 197 | 154 | 9 | 1635_DN | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 8.82e-06 | 199 | 154 | 9 | 6810_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 8.82e-06 | 199 | 154 | 9 | 6321_DN | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A | 8.82e-06 | 199 | 154 | 9 | 1511_UP | |
| Drug | fullerene C60 | UBQLN2 ARHGEF28 KIF26A DUSP7 SREBF1 PER1 MUC5B ARFIP2 SRCAP ARHGEF11 TBC1D24 STAC2 SETD5 ARHGAP31 SMARCA4 LRP5 RIPOR1 BSN MUC4 ADAMTSL4 MUC6 MED13 WNK4 FOXC2 VEGFB | 2.47e-05 | 1498 | 154 | 25 | ctd:C069837 |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.83e-05 | 177 | 154 | 8 | 985_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.83e-05 | 177 | 154 | 8 | 3462_UP | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A | 3.07e-05 | 179 | 154 | 8 | 4554_DN | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 4.03e-05 | 186 | 154 | 8 | 6891_UP | |
| Drug | Contact Lens Solutions | 4.55e-05 | 2 | 154 | 2 | ctd:D018639 | |
| Drug | dibromsalan | 4.55e-05 | 2 | 154 | 2 | CID000014839 | |
| Drug | V alone | 4.55e-05 | 2 | 154 | 2 | CID000006733 | |
| Drug | Clotrimazole [23593-75-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 5.24e-05 | 193 | 154 | 8 | 3166_UP | |
| Drug | forskolin; Up 200; 50uM; HL60; HG-U133A | 5.24e-05 | 193 | 154 | 8 | 783_UP | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 5.43e-05 | 194 | 154 | 8 | 6835_UP | |
| Drug | Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; PC3; HT_HG-U133A | 5.63e-05 | 195 | 154 | 8 | 6283_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.63e-05 | 195 | 154 | 8 | 1207_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 5.63e-05 | 195 | 154 | 8 | 1665_DN | |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.63e-05 | 195 | 154 | 8 | 4813_UP | |
| Drug | Bufexamac [2438-72-4]; Down 200; 18uM; HL60; HT_HG-U133A | 5.84e-05 | 196 | 154 | 8 | 2382_DN | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A | 5.84e-05 | 196 | 154 | 8 | 4276_DN | |
| Drug | Harpagoside [19210-12-9]; Up 200; 8uM; PC3; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 6636_UP | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; HL60; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 1869_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; MCF7; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 6261_DN | |
| Drug | Repaglinide [135062-02-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 6.50e-05 | 199 | 154 | 8 | 3558_DN | |
| Drug | Gelsemine [509-15-9]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 6.50e-05 | 199 | 154 | 8 | 4177_UP | |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 6.50e-05 | 199 | 154 | 8 | 7185_UP | |
| Drug | Atracurium besylate [64228-81-5]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 6.50e-05 | 199 | 154 | 8 | 7477_UP | |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 6.50e-05 | 199 | 154 | 8 | 7030_DN | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 6.50e-05 | 199 | 154 | 8 | 2769_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.73e-05 | 200 | 154 | 8 | 4789_DN | |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; PC3; HT_HG-U133A | 6.73e-05 | 200 | 154 | 8 | 5842_DN | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 9.48e-05 | 156 | 154 | 7 | 1010_UP | |
| Drug | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | ARHGEF28 SFSWAP PODXL AFF3 ZNF467 FOXA2 CREB3L1 CSRNP1 SNCAIP SORBS3 SNAI2 OSBPL6 BSN PBX3 WNK4 FOXC2 | 1.20e-04 | 807 | 154 | 16 | ctd:C548651 |
| Drug | bourbonal | 1.36e-04 | 3 | 154 | 2 | CID000008467 | |
| Drug | TEC-Gal | 1.36e-04 | 3 | 154 | 2 | CID003081052 | |
| Drug | Boric Acids | 1.36e-04 | 3 | 154 | 2 | ctd:D001888 | |
| Drug | MG-262; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.80e-04 | 173 | 154 | 7 | 7068_DN | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.80e-04 | 173 | 154 | 7 | 3464_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.93e-04 | 175 | 154 | 7 | 2777_UP | |
| Drug | Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; HL60; HT_HG-U133A | 2.00e-04 | 176 | 154 | 7 | 3102_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 2.00e-04 | 176 | 154 | 7 | 7047_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.07e-04 | 177 | 154 | 7 | 5745_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.07e-04 | 177 | 154 | 7 | 4770_UP | |
| Drug | trichostatin A ; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.15e-04 | 178 | 154 | 7 | 873_UP | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.15e-04 | 178 | 154 | 7 | 6220_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 2.22e-04 | 179 | 154 | 7 | 6951_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.22e-04 | 179 | 154 | 7 | 5086_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 2.30e-04 | 180 | 154 | 7 | 5950_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 2.30e-04 | 180 | 154 | 7 | 6579_UP | |
| Drug | oxolinic acid | 2.42e-04 | 45 | 154 | 4 | CID000004628 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 2.46e-04 | 182 | 154 | 7 | 6879_UP | |
| Drug | GW8510; Down 200; 10uM; PC3; HT_HG-U133A | 2.46e-04 | 182 | 154 | 7 | 7067_DN | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 2.46e-04 | 182 | 154 | 7 | 7043_UP | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A | 2.54e-04 | 183 | 154 | 7 | 1668_UP | |
| Drug | AG-1478; Up 200; 31.6uM; MCF7; HT_HG-U133A_EA | 2.54e-04 | 183 | 154 | 7 | 1141_UP | |
| Drug | AC1LAOJR | 2.70e-04 | 4 | 154 | 2 | CID000472179 | |
| Drug | Timentin | 2.70e-04 | 4 | 154 | 2 | CID006437075 | |
| Drug | diphacinone | 2.70e-04 | 4 | 154 | 2 | CID000006719 | |
| Drug | MiADMSA | 2.70e-04 | 4 | 154 | 2 | CID000164448 | |
| Drug | olaquindox | 2.70e-04 | 4 | 154 | 2 | CID000071905 | |
| Drug | celastrol; Down 200; 2.5uM; MCF7; HT_HG-U133A_EA | 2.90e-04 | 187 | 154 | 7 | 887_DN | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.90e-04 | 187 | 154 | 7 | 1070_UP | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.09e-04 | 189 | 154 | 7 | 5675_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 3.29e-04 | 191 | 154 | 7 | 4454_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 3.29e-04 | 191 | 154 | 7 | 7538_UP | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.29e-04 | 191 | 154 | 7 | 4168_DN | |
| Drug | Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 3.40e-04 | 192 | 154 | 7 | 4129_UP | |
| Drug | Isotretinoin [4759-48-2]; Up 200; 13.4uM; PC3; HT_HG-U133A | 3.51e-04 | 193 | 154 | 7 | 7315_UP | |
| Drug | Amoxapine [14028-44-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.51e-04 | 193 | 154 | 7 | 4996_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; HL60; HT_HG-U133A | 3.51e-04 | 193 | 154 | 7 | 2567_DN | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; PC3; HT_HG-U133A | 3.51e-04 | 193 | 154 | 7 | 4226_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 3.51e-04 | 193 | 154 | 7 | 1664_DN | |
| Drug | Trazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 7410_UP | |
| Drug | Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 4411_DN | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 3861_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 4559_DN | |
| Drug | Leflunomide [75706-12-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 6102_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 4284_DN | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 4952_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 7098_DN | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; PC3; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 2114_UP | |
| Drug | Chloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 5047_DN | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; PC3; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 7381_DN | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 6234_DN | |
| Drug | aspirin, USP; Down 200; 100uM; PC3; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 4428_DN | |
| Drug | Trazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 7452_UP | |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 4201_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 5241_DN | |
| Drug | Hesperetin [520-33-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 5350_UP | |
| Drug | (+,-)-Synephrine [94-07-5]; Down 200; 24uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 6798_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 4100_DN | |
| Drug | Allantoin [97-59-6]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 1678_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 3314_UP | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 6994_DN | |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 2628_DN | |
| Disease | Neurodevelopmental Disorders | 5.73e-07 | 93 | 153 | 7 | C1535926 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.03e-06 | 64 | 153 | 6 | DOID:4947 (is_marker_for) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.36e-06 | 5 | 153 | 3 | DOID:3030 (is_marker_for) | |
| Disease | hypertrophic cardiomyopathy | 8.70e-06 | 92 | 153 | 6 | EFO_0000538 | |
| Disease | allergic conjunctivitis (is_marker_for) | 1.60e-05 | 10 | 153 | 3 | DOID:11204 (is_marker_for) | |
| Disease | C-reactive protein measurement | SOX5 ZNF536 ARHGEF28 OXR1 UBE4B DNAJC6 HNRNPC CREB3L1 PHF21A ZNF106 SALL1 SETD5 RP1L1 PKD1 SMARCA4 IRS2 RERE BSN | 5.66e-05 | 1206 | 153 | 18 | EFO_0004458 |
| Disease | Fibromyxosarcoma | 7.99e-05 | 3 | 153 | 2 | C3714524 | |
| Disease | Atypical juvenile parkinsonism | 7.99e-05 | 3 | 153 | 2 | C4510873 | |
| Disease | Autism Spectrum Disorders | 8.25e-05 | 85 | 153 | 5 | C1510586 | |
| Disease | multisite chronic pain | 1.40e-04 | 95 | 153 | 5 | EFO_0010100 | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 1.59e-04 | 4 | 153 | 2 | DOID:898 (is_implicated_in) | |
| Disease | prostate cancer (is_marker_for) | 1.69e-04 | 156 | 153 | 6 | DOID:10283 (is_marker_for) | |
| Disease | mean corpuscular hemoglobin concentration | SOX5 LRRC37A2 CERS6 OVOL2 ZNF800 PTPRC SUSD1 UBR5 NCAN RP1L1 MTMR3 LRP5 IRS2 MAP2K7 MED13 BORA | 2.11e-04 | 1105 | 153 | 16 | EFO_0004528 |
| Disease | bipolar disorder | PODXL INPP4A PCLO CERS6 ANKHD1 HNRNPC SVEP1 DLC1 NCAN TMEM108 ADAMTS14 | 2.23e-04 | 577 | 153 | 11 | MONDO_0004985 |
| Disease | lung carcinoma (is_marker_for) | 2.64e-04 | 5 | 153 | 2 | DOID:3905 (is_marker_for) | |
| Disease | Delayed speech and language development | 2.64e-04 | 5 | 153 | 2 | C0454644 | |
| Disease | mucositis (biomarker_via_orthology) | 2.64e-04 | 5 | 153 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | Extraskeletal Myxoid Chondrosarcoma | 2.64e-04 | 5 | 153 | 2 | C1275278 | |
| Disease | Waardenburg Syndrome Type 2 | 2.64e-04 | 5 | 153 | 2 | C2700265 | |
| Disease | migraine disorder, type 1 diabetes mellitus | 2.64e-04 | 5 | 153 | 2 | MONDO_0005147, MONDO_0005277 | |
| Disease | age at menarche | SOX5 DNAJB12 AFF3 DNAJC6 PHF21A ZC3H4 EIF4G1 TMEM108 RERE BSN MAST3 | 2.85e-04 | 594 | 153 | 11 | EFO_0004703 |
| Disease | age-related hearing impairment | 3.02e-04 | 324 | 153 | 8 | EFO_0005782 | |
| Disease | laryngeal carcinoma (is_marker_for) | 3.95e-04 | 6 | 153 | 2 | DOID:2600 (is_marker_for) | |
| Disease | Waardenburg Syndrome | 3.95e-04 | 6 | 153 | 2 | C3266898 | |
| Disease | dentures | 4.88e-04 | 70 | 153 | 4 | EFO_0010078 | |
| Disease | dental caries, dentures | 4.88e-04 | 70 | 153 | 4 | EFO_0003819, EFO_0010078 | |
| Disease | lung carcinoma (is_implicated_in) | 5.51e-04 | 7 | 153 | 2 | DOID:3905 (is_implicated_in) | |
| Disease | cancer antigen 15.3 measurement | 5.51e-04 | 7 | 153 | 2 | EFO_0010585 | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 5.51e-04 | 7 | 153 | 2 | EFO_0020797 | |
| Disease | Headache, HOMA-B | 5.51e-04 | 7 | 153 | 2 | EFO_0004469, HP_0002315 | |
| Disease | Polycystic kidney disease, type 2 | 5.51e-04 | 7 | 153 | 2 | C2751306 | |
| Disease | polycystic liver disease (implicated_via_orthology) | 5.51e-04 | 7 | 153 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 5.66e-04 | 447 | 153 | 9 | C3714756 | |
| Disease | irritable bowel syndrome | 6.18e-04 | 131 | 153 | 5 | EFO_0000555 | |
| Disease | common bile duct neoplasm (is_marker_for) | 7.33e-04 | 8 | 153 | 2 | DOID:4608 (is_marker_for) | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 7.33e-04 | 8 | 153 | 2 | C0887850 | |
| Disease | hematocrit | TRIM46 SOX5 NUMBL INSR AFF3 SREBF1 MCRIP1 SALL1 SUSD1 ZC3H4 MITF MTMR3 IRS2 BSN | 8.18e-04 | 1011 | 153 | 14 | EFO_0004348 |
| Disease | glucose measurement | 8.61e-04 | 380 | 153 | 8 | EFO_0004468 | |
| Disease | mean platelet volume | MICAL1 TCF12 AFF3 NFASC SMOC2 SRCAP SVEP1 STAC2 PTPRC ANKRD11 RIPOR1 AKAP10 IRS2 PBX1 | 8.91e-04 | 1020 | 153 | 14 | EFO_0004584 |
| Disease | Polycystic Kidney, Autosomal Dominant | 9.39e-04 | 9 | 153 | 2 | C0085413 | |
| Disease | reticulocyte count | ARHGEF28 OXR1 INSR STAC2 ZNF800 PTPRC SUSD1 ZC3H4 PKD1 MTMR3 LRP5 AKAP10 IRS2 BSN | 1.12e-03 | 1045 | 153 | 14 | EFO_0007986 |
| Disease | renal Wilms' tumor (is_implicated_in) | 1.17e-03 | 10 | 153 | 2 | DOID:5176 (is_implicated_in) | |
| Disease | dry eye syndrome (is_marker_for) | 1.17e-03 | 10 | 153 | 2 | DOID:10140 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 1.17e-03 | 10 | 153 | 2 | DOID:10754 (is_marker_for) | |
| Disease | cancer antigen 125 measurement | 1.17e-03 | 10 | 153 | 2 | EFO_0010603 | |
| Disease | reticulocyte measurement | ARHGEF28 OXR1 INSR AFF3 PER1 ZNF800 PTPRC SUSD1 ZC3H4 EIF4G1 MTMR3 LRP5 IRS2 BSN | 1.21e-03 | 1053 | 153 | 14 | EFO_0010700 |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.24e-03 | 153 | 153 | 5 | EFO_0004611, EFO_0020944 | |
| Disease | biological sex | 1.31e-03 | 230 | 153 | 6 | PATO_0000047 | |
| Disease | unipolar depression, bipolar disorder | 1.35e-03 | 156 | 153 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | ceramide measurement | 1.46e-03 | 235 | 153 | 6 | EFO_0010222 | |
| Disease | Inhalant adrenergic use measurement | 1.59e-03 | 96 | 153 | 4 | EFO_0009941 | |
| Disease | susceptibility to pneumonia measurement | 1.66e-03 | 97 | 153 | 4 | EFO_0008410 | |
| Disease | spontaneous preterm birth | 1.92e-03 | 101 | 153 | 4 | EFO_0006917 | |
| Disease | pancreatic cancer (is_marker_for) | 1.92e-03 | 101 | 153 | 4 | DOID:1793 (is_marker_for) | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 2.01e-03 | 13 | 153 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Cakut | 2.01e-03 | 13 | 153 | 2 | C1968949 | |
| Disease | cortical thickness | SOX5 ZNF536 SREBF1 SMOC2 ZNF106 DLC1 SETD5 PKD1 MITF MTMR3 AKAP10 TMEM108 RERE FOXC2 | 2.02e-03 | 1113 | 153 | 14 | EFO_0004840 |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 2.02e-03 | 171 | 153 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | creatinine measurement | TRIM46 SOX5 ATF7 TCF12 INPP4A STAC2 DLC1 CELSR3 MITF MTMR3 ANKRD11 BSN MUC1 | 2.10e-03 | 995 | 153 | 13 | EFO_0004518 |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.11e-03 | 49 | 153 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.11e-03 | 49 | 153 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | red blood cell density measurement | PODXL AFF3 ARHGEF11 OVOL2 ZNF106 SALL1 PTPRC UBR5 ZC3H4 MITF IRS2 MUC4 | 2.19e-03 | 880 | 153 | 12 | EFO_0007978 |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 2.33e-03 | 14 | 153 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 2.33e-03 | 14 | 153 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | African Burkitt's lymphoma | 2.68e-03 | 15 | 153 | 2 | C0343640 | |
| Disease | Burkitt Leukemia | 2.68e-03 | 15 | 153 | 2 | C4721444 | |
| Disease | venous thromboembolism | 2.85e-03 | 460 | 153 | 8 | EFO_0004286 | |
| Disease | Cardiovascular Abnormalities | 3.06e-03 | 16 | 153 | 2 | C0243050 | |
| Disease | Drug habituation | 3.08e-03 | 115 | 153 | 4 | C0013170 | |
| Disease | Drug abuse | 3.08e-03 | 115 | 153 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.08e-03 | 115 | 153 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.08e-03 | 115 | 153 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.08e-03 | 115 | 153 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.08e-03 | 115 | 153 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.08e-03 | 115 | 153 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.08e-03 | 115 | 153 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.08e-03 | 115 | 153 | 4 | C0029231 | |
| Disease | Substance abuse problem | 3.17e-03 | 116 | 153 | 4 | C0740858 | |
| Disease | intelligence, self reported educational attainment | 3.27e-03 | 117 | 153 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | sphingomyelin measurement | 3.37e-03 | 278 | 153 | 6 | EFO_0010118 | |
| Disease | Cleft palate, cleft lip | 3.43e-03 | 279 | 153 | 6 | EFO_0003959, HP_0000175 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 3.45e-03 | 17 | 153 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | otitis media (biomarker_via_orthology) | 3.45e-03 | 17 | 153 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.45e-03 | 17 | 153 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Insulin Resistance | 3.77e-03 | 60 | 153 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 3.77e-03 | 60 | 153 | 3 | C0920563 | |
| Disease | Adrenocortical carcinoma | 3.87e-03 | 18 | 153 | 2 | C0206686 | |
| Disease | Tourette syndrome, schizophrenia | 3.87e-03 | 18 | 153 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 3.95e-03 | 61 | 153 | 3 | DOID:3587 (is_marker_for) | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 3.96e-03 | 200 | 153 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Malignant neoplasm of breast | MICAL1 LRRC37A2 MED14 PER1 PTPRC LRRC37A SNAI2 MTMR3 ZBTB3 MAP2K7 TOP2A PLXNB1 VEGFB | 4.02e-03 | 1074 | 153 | 13 | C0006142 |
| Disease | cystic fibrosis (is_marker_for) | 4.13e-03 | 62 | 153 | 3 | DOID:1485 (is_marker_for) | |
| Disease | hypertension, white matter hyperintensity measurement | 4.13e-03 | 62 | 153 | 3 | EFO_0000537, EFO_0005665 | |
| Disease | Congenital hernia of foramen of Morgagni | 4.31e-03 | 19 | 153 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 4.31e-03 | 19 | 153 | 2 | C0265700 | |
| Disease | docosahexaenoic acid measurement | 4.39e-03 | 127 | 153 | 4 | EFO_0007761 | |
| Disease | Stomach Neoplasms | 4.65e-03 | 297 | 153 | 6 | C0038356 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 4.72e-03 | 65 | 153 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | chronic kidney disease (is_marker_for) | 4.77e-03 | 20 | 153 | 2 | DOID:784 (is_marker_for) | |
| Disease | Malignant neoplasm of stomach | 4.88e-03 | 300 | 153 | 6 | C0024623 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGSTTTTSPGPPAAH | 231 | O60241 | |
| APATKDSESAPPSHT | 791 | P51826 | |
| DSESAPPSHTSDTPA | 796 | P51826 | |
| PTPPSSHGSDSDGSQ | 206 | Q96BA8 | |
| DSQHSTPVPTAPTSA | 1741 | Q6UB99 | |
| QASGTEPPSPTHSLG | 256 | Q6UY14 | |
| VDLPSSSDPPTSASH | 46 | Q8N2A0 | |
| PASTHVGTASSFPPE | 456 | Q8IZF6 | |
| GPPDESHPGSSDSSA | 531 | O43572 | |
| SDSPTKSSSTEPSPH | 951 | Q7Z2Y8 | |
| PSGPPDSSTDHSEAP | 1366 | O15085 | |
| PSHSTTPSGPGDEVA | 71 | P53365 | |
| GPTHAFSSPSESPDS | 1156 | Q9ULJ7 | |
| SSGSISPSGHPIPSE | 241 | P17544 | |
| TEPGAAHTSSPQPST | 1196 | Q9C0C7 | |
| PSPESAYTAETTSPH | 106 | Q9UBU7 | |
| AASPGAEAPSSSEPH | 31 | Q9UER7 | |
| LSSPHLPGTSSAAPD | 461 | Q8IXJ9 | |
| DTSSPGTQHPFAPET | 1156 | Q8WXS8 | |
| HVSPTPATTSPGEKG | 261 | Q9Y6R0 | |
| PSPGTTTPGHTTATS | 2266 | Q9HC84 | |
| EPSTGTSHTPAATTG | 2786 | Q9HC84 | |
| EAHSSSPAGSPPSEP | 781 | O43374 | |
| EAHSSSPAGSPPSEP | 781 | C9J798 | |
| TTHCSPPPEESSPGE | 611 | Q96PE3 | |
| DTLSSHDVPGSPTAS | 1311 | Q8N1W1 | |
| SVPPSASHVAPTETF | 501 | P00450 | |
| PLTHPSPSGEETAGS | 791 | Q8WXI7 | |
| PLGSHPTTNTETSIP | 2206 | Q8WXI7 | |
| GVTESPLHPSSTSPS | 2716 | Q8WXI7 | |
| PDISPEASSSHSNSP | 6131 | Q8WXI7 | |
| KTQTDPPGSTPESTH | 8201 | Q8WXI7 | |
| PPGSTPESTHTVDIS | 8206 | Q8WXI7 | |
| TPSGSSHSSPVPVTS | 9451 | Q8WXI7 | |
| TSHGEEASSAIPTPT | 10911 | Q8WXI7 | |
| SATFPTVPESPHESE | 11331 | Q8WXI7 | |
| PSPGEPETTASSATH | 11651 | Q8WXI7 | |
| PVTSPSSASTGHATP | 1186 | Q99102 | |
| SPSSASTGHATPLPV | 1301 | Q99102 | |
| PSAASTGHTTPLPVT | 1446 | Q99102 | |
| PVTNPSSASTGHATP | 2066 | Q99102 | |
| PLPVTSPSSASTGHA | 2336 | Q99102 | |
| STGHTTPLPVTDTPS | 2506 | Q99102 | |
| PVTSPSSASTGHATP | 2626 | Q99102 | |
| TGHATPLPDTDTSSA | 2971 | Q99102 | |
| PLPDTDTSSASTGHA | 2976 | Q99102 | |
| SPSSASTGHATPLPV | 3061 | Q99102 | |
| PVTSPSSASTGHTTP | 3106 | Q99102 | |
| PVTSPSSASTGHATP | 3186 | Q99102 | |
| PLPVTSPSSASTGHA | 3856 | Q99102 | |
| SPSSASTGHATPLPV | 3861 | Q99102 | |
| TGHATPLPVTSPSSA | 4011 | Q99102 | |
| PLPVTSPSSASTGHA | 4016 | Q99102 | |
| SPSSASTGHATPVPV | 4021 | Q99102 | |
| FTTHSPPTGSSPFSS | 1966 | Q6W4X9 | |
| PSSHSSPQTSSPSVG | 2146 | Q6W4X9 | |
| PSSVTSPTEGPGSVH | 411 | P40424 | |
| SSVTSPTEGPGSVHS | 416 | P40426 | |
| QPTSTHPVATPTSSG | 191 | O00592 | |
| QGGHSRTSSPTPPSS | 326 | P40425 | |
| PSSVTSPTEGPGSVH | 411 | P40425 | |
| HSPEPPEGTKSTASS | 286 | A8MTJ6 | |
| TITPEPTTEVGHSTP | 616 | O60309 | |
| PSPVPSQTGSTDAHT | 216 | Q5SZI1 | |
| VSSSPTPSSDLPSHD | 781 | Q8NEZ4 | |
| GSVTEHPSPSPLLSS | 106 | P07910 | |
| TSAAPEPHPSTSTAQ | 1121 | Q14676 | |
| TITPEPTTEVGHSTP | 616 | A6NM11 | |
| TITPEPTTEVGHSTP | 616 | A6NMS7 | |
| APPSPAKSSSVDSSH | 901 | Q6PRD1 | |
| SSASSDSPHPVITPS | 176 | Q8N307 | |
| SESSASSDGPHPVIT | 231 | Q8N307 | |
| ESSASSDGPHPVITP | 251 | Q8N307 | |
| SSASSDGPHPVITPS | 271 | Q8N307 | |
| SESSASSDGPHPVIT | 326 | Q8N307 | |
| SSASSDGPHPVITPS | 366 | Q8N307 | |
| SASGTSEAPDCPTHP | 361 | Q96S65 | |
| PSDDSPAHSSAIGPV | 1376 | O75197 | |
| PALGSTTPPAHDVTS | 106 | P15941 | |
| SSCTGTFHPAPSVPE | 1911 | Q9UPA5 | |
| TSPGPLHSPGSSSDS | 516 | O15534 | |
| HSGPTSAGSSSVPSP | 4651 | Q9Y6V0 | |
| SSPGSTGSPLHEEPS | 746 | O43157 | |
| GGSRSPSSESSPQHP | 51 | O14733 | |
| TGTQTGPPTHTSTAP | 4191 | Q02817 | |
| TTSGGHTLSPPPSTT | 4261 | Q02817 | |
| SETSTPSEHSAAPSP | 151 | Q92614 | |
| SEPHLGSPSQPTSTA | 101 | Q9C000 | |
| SPETHQEPSISETPS | 71 | A6H8Z2 | |
| HTSSSFPSNPSTPVG | 351 | Q99081 | |
| GALTPTSPQSSHPDS | 441 | Q96BD5 | |
| STASSTLGPHSPEPL | 731 | O75074 | |
| HGGPSLAPPSTTTSS | 156 | Q9ULI4 | |
| HSPGPVSQASPGTSS | 616 | Q8TDZ2 | |
| EALSDHPSGPTSPLS | 356 | Q99958 | |
| LSPTEGPHSAGSSTP | 31 | Q6ZVL6 | |
| LDASPTSPTGPAHGT | 591 | Q96KJ4 | |
| PNTSSTSVPTSPEEH | 781 | P06213 | |
| SSSPHAPESETPEPG | 71 | Q9BRP0 | |
| PVAGPSSEPSAHTST | 326 | Q9H5V7 | |
| TPPSHLTDPLESSTD | 356 | Q9BZF3 | |
| TEPPTSTEHSGSPGA | 346 | Q9P2V4 | |
| SPVPDASHSPRAGTS | 1136 | O60244 | |
| TNPDVHPTEATPSST | 176 | Q8N573 | |
| AHSPPAATSPGSLSS | 436 | Q9Y4H2 | |
| PPTTTSGTKIHESAP | 1101 | O94856 | |
| SSSTSAEKFPSPHPS | 316 | O14681 | |
| DSLPSASPGSPHSGV | 206 | Q6PGQ7 | |
| TAGDQPPPTDTTHAT | 56 | Q9NXW2 | |
| PPLGPDSSHSSSSDG | 516 | Q9NX05 | |
| DVFHPSGPASTQSTP | 546 | O75061 | |
| PSSATESDGSPVPSS | 226 | Q16829 | |
| GAESSSTSLHPSDPV | 411 | Q02410 | |
| TLTPSPSPKGHTAES | 736 | Q68DC2 | |
| DSEPPGKNPHTATTT | 351 | Q6ZMG9 | |
| EHSPSESQPSSPSPT | 251 | Q04637 | |
| STTSPGVASHPATVP | 1076 | Q6MZM0 | |
| SPPSSSEIFTPAHEE | 21 | C9JLW8 | |
| SPSSSSPASPAAAGH | 1141 | O60307 | |
| AVPGSPVGPSTSTHS | 21 | Q96G42 | |
| SSTSSHPGGRPTTAP | 181 | Q14689 | |
| ETPTSHFAVSPGTPE | 406 | Q6BAA4 | |
| TPLGPHTTATPSATA | 3266 | Q9NYQ7 | |
| PPGSVSATPHTTSSV | 1581 | Q7Z5N4 | |
| SPQDSKDTPTSHVPS | 1096 | Q9NSC2 | |
| KDTPTSHVPSGPLSS | 1101 | Q9NSC2 | |
| PISPHLSGPAEDSSS | 581 | Q9P1Z2 | |
| DSGSDVSSISHPTSP | 456 | Q3KP66 | |
| HPTSPGSSSPDISFL | 466 | Q3KP66 | |
| PPHFTEPSVSLSTSE | 101 | Q8N769 | |
| PPSSHGSDSEGSLSP | 206 | Q70SY1 | |
| SHSGRPSATSSPDQP | 996 | Q13615 | |
| ETSEPFTTHSFPTPG | 1761 | P98161 | |
| EQPSSTHDSPTATSP | 321 | Q5THK1 | |
| STSVTPHSPSSPVGS | 106 | O75928 | |
| ETPAGTESPHSSASP | 296 | Q9Y261 | |
| DSSTPTPHNADGAPV | 336 | Q12872 | |
| GDPSSEPTSPASTPS | 71 | Q7Z4K8 | |
| GSSSTESSPEHPPKS | 1651 | Q9UQ35 | |
| EGSSPEPPPESHSSS | 1006 | O75151 | |
| GSTEDGLPPSHSSPS | 981 | A5PKW4 | |
| HPDSPSSSSPPSTQE | 556 | Q3MII6 | |
| GTAASSHTEVAPTDP | 461 | O14594 | |
| PVSPPGEASTSGQHS | 151 | Q9NQW5 | |
| VSPPPPSDTSSKDHS | 86 | O43623 | |
| GSEHASSPVPASGPS | 126 | P51532 | |
| DAHSAPPTTSSQAPS | 211 | Q96LK8 | |
| PGNPPSHGSSESSLS | 1281 | Q9C0A6 | |
| SPAHPVSTDSLAPFT | 1301 | Q9C0A6 | |
| PSAPPHTSGVSLGES | 366 | Q6IA17 | |
| HSPSPTSESSEPDLE | 746 | Q9Y6H5 | |
| PEPTVVDTPSHASQS | 1116 | Q9P2R6 | |
| ADTSGVPSIPQTHSP | 481 | P48436 | |
| SSSLPTQPHPDVSES | 1601 | Q9UHV7 | |
| GPSSPSQTPSSHDSD | 346 | Q6ZRS2 | |
| ENHTSPPGSTSPEDC | 346 | Q4LDE5 | |
| GSLPSHAPPSEDAAT | 601 | Q96QB1 | |
| GLPSPSDTTSVYHSP | 511 | P36956 | |
| APETHPSSSPTPTSS | 2061 | Q8IWZ3 | |
| SDSTEQSPHSLPSDP | 686 | Q969H4 | |
| QSHPSPSSEVTGPTF | 216 | P24278 | |
| AEPTAPLSHSASSDP | 461 | Q9ULP9 | |
| HSPPGTGSSEDASTP | 46 | Q5M7Z0 | |
| SSAEHPGASKPPISS | 36 | O75030 | |
| TEPPSHLSETDPSAS | 1451 | Q8IWN7 | |
| TPDSIASSSSAAHPP | 206 | Q92734 | |
| PSSSSGRLSEPDPSH | 331 | Q9H3U7 | |
| PDDAATHSPPGTVSA | 11 | Q6ZMT1 | |
| GPEPFHPTTDATSCT | 161 | Q6UWL2 | |
| PSTPLSPHSAASGTA | 306 | O95155 | |
| SPSHAGTTPPENGLS | 191 | P23497 | |
| TPESSSHTPTPGTQG | 281 | Q96S82 | |
| PSHPLDLGTSSPNTS | 596 | O60504 | |
| SSPSVQDSTSPGEHP | 1071 | Q2M1Z3 | |
| PPGEAPTTPSSSDEH | 546 | Q5SNT2 | |
| KTPSGTPDHSSSSPA | 216 | Q9NPC8 | |
| PEGSLHSSPVGPSSS | 901 | Q9UPT8 | |
| ASSVSSSPSPPFGHS | 146 | P50616 | |
| QEDSPHPSSPSSSDI | 711 | O15090 | |
| AHAAPSTTSALTPGP | 176 | P49765 | |
| SPSLPPTHASDSGSS | 66 | P58753 | |
| SSSPPATHFPDETEI | 1391 | P11388 | |
| PTDPLSHSSNSSSEP | 406 | Q96S55 | |
| EPADSVESSPPSITH | 411 | Q2TB10 | |
| LPSEHSSVSSSPEPG | 691 | P35711 | |
| AAPSETTSPTSESGP | 541 | Q9UHD9 | |
| TGSVPTSTDPAPSAH | 516 | Q6ZS17 | |
| SSDPLPTHTTAFSPA | 46 | P08575 | |
| SPSPHTAEVESEASP | 976 | Q96J92 | |
| SPTFQTHGSVPAPDS | 1181 | Q9H2Y7 | |
| SPDSSASPHSTAPSP | 331 | Q7Z7K2 | |
| AGASSSDHQDPVSPP | 1006 | O95071 | |
| APHSESSLSTGPAPA | 106 | Q6UXF1 | |
| HPPVADVSLASPSSS | 261 | Q9H5J0 | |
| HSSPGPTDTTLSPGS | 696 | Q9UKN1 | |
| PGSTPTTHFPASSTT | 2251 | Q9UKN1 |